WO1997031892A1 - Derives d'acide hydroxamique - Google Patents
Derives d'acide hydroxamique Download PDFInfo
- Publication number
- WO1997031892A1 WO1997031892A1 PCT/JP1997/000582 JP9700582W WO9731892A1 WO 1997031892 A1 WO1997031892 A1 WO 1997031892A1 JP 9700582 W JP9700582 W JP 9700582W WO 9731892 A1 WO9731892 A1 WO 9731892A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- carbon atoms
- compound
- substituted
- alkyl group
- Prior art date
Links
- 239000002253 acid Substances 0.000 title description 53
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 530
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 144
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 45
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 16
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 14
- 125000002252 acyl group Chemical group 0.000 claims abstract description 11
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 5
- -1 7-methyloctyl Chemical group 0.000 claims description 625
- 125000004432 carbon atom Chemical group C* 0.000 claims description 269
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 210
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 208
- 125000001424 substituent group Chemical group 0.000 claims description 98
- 150000002148 esters Chemical class 0.000 claims description 57
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 56
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 49
- 125000003545 alkoxy group Chemical group 0.000 claims description 38
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 31
- 125000001931 aliphatic group Chemical group 0.000 claims description 30
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 23
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 22
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 22
- 125000005843 halogen group Chemical group 0.000 claims description 21
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 21
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 19
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 19
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 19
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 17
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 16
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 13
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 11
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 11
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 11
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 9
- 125000004104 aryloxy group Chemical group 0.000 claims description 9
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 9
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- 206010027476 Metastases Diseases 0.000 claims description 7
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims description 7
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 7
- 230000009401 metastasis Effects 0.000 claims description 7
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 7
- 201000008482 osteoarthritis Diseases 0.000 claims description 7
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 7
- 125000004429 atom Chemical group 0.000 claims description 6
- 150000001721 carbon Chemical group 0.000 claims description 6
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 230000009545 invasion Effects 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000002950 monocyclic group Chemical group 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 claims description 3
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 3
- 125000004344 phenylpropyl group Chemical group 0.000 claims description 3
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims description 2
- 229960002944 cyclofenil Drugs 0.000 claims description 2
- 230000035755 proliferation Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 2
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 claims 1
- 208000025747 Rheumatic disease Diseases 0.000 claims 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims 1
- 229910052785 arsenic Inorganic materials 0.000 claims 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims 1
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 229960005224 roxithromycin Drugs 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract description 13
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 10
- 239000011159 matrix material Substances 0.000 abstract description 10
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 239000002257 antimetastatic agent Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 319
- 238000006243 chemical reaction Methods 0.000 description 242
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 228
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 174
- 239000000243 solution Substances 0.000 description 158
- 239000002904 solvent Substances 0.000 description 148
- 238000000034 method Methods 0.000 description 142
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 120
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 112
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 104
- 238000001819 mass spectrum Methods 0.000 description 102
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 99
- 238000000862 absorption spectrum Methods 0.000 description 95
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 91
- 239000000203 mixture Substances 0.000 description 90
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 82
- 239000012442 inert solvent Substances 0.000 description 78
- 230000002829 reductive effect Effects 0.000 description 75
- 239000008188 pellet Substances 0.000 description 74
- 239000012044 organic layer Substances 0.000 description 73
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 66
- 239000011541 reaction mixture Substances 0.000 description 55
- 239000007858 starting material Substances 0.000 description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 50
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 50
- 238000007796 conventional method Methods 0.000 description 50
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 48
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 46
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 46
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 45
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 43
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 42
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
- 239000007787 solid Substances 0.000 description 42
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 36
- 238000001953 recrystallisation Methods 0.000 description 36
- 238000010898 silica gel chromatography Methods 0.000 description 34
- 238000001704 evaporation Methods 0.000 description 33
- 239000002585 base Substances 0.000 description 31
- 235000019441 ethanol Nutrition 0.000 description 31
- 239000007864 aqueous solution Substances 0.000 description 30
- 238000001914 filtration Methods 0.000 description 30
- 230000035484 reaction time Effects 0.000 description 30
- 239000012230 colorless oil Substances 0.000 description 29
- 150000002894 organic compounds Chemical class 0.000 description 29
- 239000003960 organic solvent Substances 0.000 description 29
- 238000001226 reprecipitation Methods 0.000 description 29
- 239000013598 vector Substances 0.000 description 29
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 28
- 238000000746 purification Methods 0.000 description 27
- 150000001408 amides Chemical class 0.000 description 25
- 150000002170 ethers Chemical class 0.000 description 25
- 238000002844 melting Methods 0.000 description 25
- 230000008018 melting Effects 0.000 description 25
- 229910052938 sodium sulfate Inorganic materials 0.000 description 25
- 235000011152 sodium sulphate Nutrition 0.000 description 25
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 24
- 239000007788 liquid Substances 0.000 description 24
- 150000001412 amines Chemical class 0.000 description 23
- 239000000843 powder Substances 0.000 description 23
- 239000003795 chemical substances by application Substances 0.000 description 22
- 239000013078 crystal Substances 0.000 description 22
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 22
- 235000017557 sodium bicarbonate Nutrition 0.000 description 22
- 239000000126 substance Substances 0.000 description 22
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 20
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 20
- 125000006239 protecting group Chemical group 0.000 description 20
- 238000009833 condensation Methods 0.000 description 19
- 230000005494 condensation Effects 0.000 description 19
- 238000000921 elemental analysis Methods 0.000 description 19
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 18
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 18
- 238000000926 separation method Methods 0.000 description 16
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000002994 raw material Substances 0.000 description 15
- 229920006395 saturated elastomer Polymers 0.000 description 15
- 238000005406 washing Methods 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 14
- 238000010511 deprotection reaction Methods 0.000 description 14
- 239000012046 mixed solvent Substances 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 12
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 12
- 239000012299 nitrogen atmosphere Substances 0.000 description 12
- 150000008065 acid anhydrides Chemical class 0.000 description 11
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 11
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 11
- 150000001298 alcohols Chemical class 0.000 description 10
- 150000008282 halocarbons Chemical class 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 238000012746 preparative thin layer chromatography Methods 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 230000029936 alkylation Effects 0.000 description 9
- 238000005804 alkylation reaction Methods 0.000 description 9
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 239000003638 chemical reducing agent Substances 0.000 description 8
- 239000007800 oxidant agent Substances 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- 239000006187 pill Substances 0.000 description 8
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 7
- 230000010933 acylation Effects 0.000 description 7
- 238000005917 acylation reaction Methods 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000003818 flash chromatography Methods 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical group C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 7
- 125000004076 pyridyl group Chemical group 0.000 description 7
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- WQLRWAAGMBYJEC-LLVKDONJSA-N C(CCCCCCCC)[C@@H](C(=O)N)CC(=O)N Chemical compound C(CCCCCCCC)[C@@H](C(=O)N)CC(=O)N WQLRWAAGMBYJEC-LLVKDONJSA-N 0.000 description 6
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 6
- HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 6
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 125000001309 chloro group Chemical group Cl* 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 230000003301 hydrolyzing effect Effects 0.000 description 5
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 5
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- LTIWPWOZZLWUGE-CYBMUJFWSA-N (2R)-5-(4-chlorophenyl)-2-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]pentanoic acid Chemical compound CC(C)(C)OC(=O)C[C@@H](CCCC1=CC=C(C=C1)Cl)C(=O)O LTIWPWOZZLWUGE-CYBMUJFWSA-N 0.000 description 4
- JBULSURVMXPBNA-RXMQYKEDSA-N (2s)-2-amino-3,3-dimethylbutan-1-ol Chemical compound CC(C)(C)[C@H](N)CO JBULSURVMXPBNA-RXMQYKEDSA-N 0.000 description 4
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 4
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 101150065749 Churc1 gene Proteins 0.000 description 4
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 102100038239 Protein Churchill Human genes 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 239000003039 volatile agent Substances 0.000 description 4
- UCDDEHHXEDLYRH-CYBMUJFWSA-N (2r)-2-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]decanoic acid Chemical compound CCCCCCCC[C@@H](C(O)=O)CC(=O)OC(C)(C)C UCDDEHHXEDLYRH-CYBMUJFWSA-N 0.000 description 3
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 3
- FYELSNVLZVIGTI-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1CC)CC(=O)N1CC2=C(CC1)NN=N2 FYELSNVLZVIGTI-UHFFFAOYSA-N 0.000 description 3
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 3
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- QJNLUNBGDFUULX-UHFFFAOYSA-N 4-n,4-n'-dimethyl-3h-pyridine-4,4-diamine Chemical compound CNC1(NC)CC=NC=C1 QJNLUNBGDFUULX-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- 108010026132 Gelatinases Proteins 0.000 description 3
- 102000013382 Gelatinases Human genes 0.000 description 3
- 102000011722 Matrix Metalloproteinase 13 Human genes 0.000 description 3
- 108010076503 Matrix Metalloproteinase 13 Proteins 0.000 description 3
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 3
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000003377 acid catalyst Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 3
- 238000010531 catalytic reduction reaction Methods 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 150000001879 copper Chemical class 0.000 description 3
- UCDHYFZYUGDETN-UHFFFAOYSA-N cyanophosphonic acid Chemical compound OP(O)(=O)C#N UCDHYFZYUGDETN-UHFFFAOYSA-N 0.000 description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- DUVOZUPPHBRJJO-UHFFFAOYSA-N ethyl 2-isocyanatoacetate Chemical compound CCOC(=O)CN=C=O DUVOZUPPHBRJJO-UHFFFAOYSA-N 0.000 description 3
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 description 3
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 238000004237 preparative chromatography Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 3
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 3
- 239000001384 succinic acid Substances 0.000 description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- XPWWRSIBXKFKTA-QMMMGPOBSA-N (2s)-2-(cyclohexylamino)propan-1-ol Chemical compound OC[C@H](C)NC1CCCCC1 XPWWRSIBXKFKTA-QMMMGPOBSA-N 0.000 description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 2
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 2
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 2
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000005978 1-naphthyloxy group Chemical group 0.000 description 2
- 125000005808 2,4,6-trimethoxyphenyl group Chemical group [H][#6]-1=[#6](-[#8]C([H])([H])[H])-[#6](-*)=[#6](-[#8]C([H])([H])[H])-[#6]([H])=[#6]-1-[#8]C([H])([H])[H] 0.000 description 2
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 2
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 2
- YZBOVSFWWNVKRJ-UHFFFAOYSA-M 2-butoxycarbonylbenzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1C([O-])=O YZBOVSFWWNVKRJ-UHFFFAOYSA-M 0.000 description 2
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 2
- 125000005916 2-methylpentyl group Chemical group 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 2
- 125000004361 3,4,5-trifluorophenyl group Chemical group [H]C1=C(F)C(F)=C(F)C([H])=C1* 0.000 description 2
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 2
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 2
- 125000005917 3-methylpentyl group Chemical group 0.000 description 2
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- GTYRNUBCKLRLBR-YADHBBJMSA-N CCCCCCCCC[C@H](CC(=O)O)C(=O)N[C@@H](CC1CCCCC1)COC(=O)C Chemical compound CCCCCCCCC[C@H](CC(=O)O)C(=O)N[C@@H](CC1CCCCC1)COC(=O)C GTYRNUBCKLRLBR-YADHBBJMSA-N 0.000 description 2
- ZQRNLHCYRUVCGQ-UHFFFAOYSA-N CCOC(C(C)C(OCCC(C)(C)C)=O)=O Chemical compound CCOC(C(C)C(OCCC(C)(C)C)=O)=O ZQRNLHCYRUVCGQ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 229940126062 Compound A Drugs 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 238000010533 azeotropic distillation Methods 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Inorganic materials [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 210000002469 basement membrane Anatomy 0.000 description 2
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N cycloheptane Chemical compound C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 230000020176 deacylation Effects 0.000 description 2
- 238000005947 deacylation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 238000005906 dihydroxylation reaction Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- PDIOPTPBTWLDDG-UHFFFAOYSA-N diphenoxyphosphorylformonitrile Chemical compound C=1C=CC=CC=1OP(C#N)(=O)OC1=CC=CC=C1 PDIOPTPBTWLDDG-UHFFFAOYSA-N 0.000 description 2
- YPLYFEUBZLLLIY-UHFFFAOYSA-N dipropan-2-yl butanedioate Chemical compound CC(C)OC(=O)CCC(=O)OC(C)C YPLYFEUBZLLLIY-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- KWBIXTIBYFUAGV-UHFFFAOYSA-N ethylcarbamic acid Chemical compound CCNC(O)=O KWBIXTIBYFUAGV-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 2
- FGKJLKRYENPLQH-UHFFFAOYSA-N isocaproic acid Chemical compound CC(C)CCC(O)=O FGKJLKRYENPLQH-UHFFFAOYSA-N 0.000 description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 229950009215 phenylbutanoic acid Drugs 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 229940090181 propyl acetate Drugs 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- FEQPHYCEZKWPNE-UHFFFAOYSA-K trichlororhodium;triphenylphosphane Chemical compound Cl[Rh](Cl)Cl.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 FEQPHYCEZKWPNE-UHFFFAOYSA-K 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- TUFCXHVVCOIDOK-XZOQPEGZSA-N (2r,3s)-3-(dibenzylamino)-2-hydroxy-4-phenylbutanoic acid Chemical compound C([C@@H]([C@@H](O)C(O)=O)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)C1=CC=CC=C1 TUFCXHVVCOIDOK-XZOQPEGZSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LHOIAFAJRRSRRQ-UHFFFAOYSA-N 1,1-dimethyl-2-pyridin-4-ylhydrazine Chemical compound CN(C)NC1=CC=NC=C1 LHOIAFAJRRSRRQ-UHFFFAOYSA-N 0.000 description 1
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
- XXCVBOQRPQKVKY-UHFFFAOYSA-N 1,2,4-triphenylbenzene Chemical group C1=CC=CC=C1C(C=C1C=2C=CC=CC=2)=CC=C1C1=CC=CC=C1 XXCVBOQRPQKVKY-UHFFFAOYSA-N 0.000 description 1
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- JILHZKWLEAKYRC-UHFFFAOYSA-N 1-methoxy-2,2-dimethylpropane Chemical compound COCC(C)(C)C JILHZKWLEAKYRC-UHFFFAOYSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical group CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 1
- AVMSWPWPYJVYKY-UHFFFAOYSA-N 2-Methylpropyl formate Chemical compound CC(C)COC=O AVMSWPWPYJVYKY-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- XFKCVVFQGHCLIP-UHFFFAOYSA-N 2-ethylbutanedioyl dichloride Chemical compound CCC(C(Cl)=O)CC(Cl)=O XFKCVVFQGHCLIP-UHFFFAOYSA-N 0.000 description 1
- XQLZOHAPUMSJPK-UHFFFAOYSA-N 2-ethyltridecanamide Chemical compound C(C)C(C(=O)N)CCCCCCCCCCC XQLZOHAPUMSJPK-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- RVGLUKRYMXEQAH-UHFFFAOYSA-N 3,3-dimethyloxetane Chemical compound CC1(C)COC1 RVGLUKRYMXEQAH-UHFFFAOYSA-N 0.000 description 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000003469 3-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- LQLJNIMZZWZZLE-UHFFFAOYSA-N 4-(iminomethylideneamino)-n,n-dimethylpentan-1-amine;hydrochloride Chemical compound Cl.N=C=NC(C)CCCN(C)C LQLJNIMZZWZZLE-UHFFFAOYSA-N 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-M 4-phenylbutyrate Chemical compound [O-]C(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-M 0.000 description 1
- VBHRLSQLJDHSCO-UHFFFAOYSA-N 5,5-dimethylhexanoic acid Chemical compound CC(C)(C)CCCC(O)=O VBHRLSQLJDHSCO-UHFFFAOYSA-N 0.000 description 1
- YKKKNWFYJMOSLZ-UHFFFAOYSA-N 6-(4-chlorophenyl)hexanoic acid Chemical compound OC(=O)CCCCCC1=CC=C(Cl)C=C1 YKKKNWFYJMOSLZ-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- AMKGKYQBASDDJB-UHFFFAOYSA-N 9$l^{2}-borabicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1[B]2 AMKGKYQBASDDJB-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- WBZSLZLPWSGTOM-BJKOFHAPSA-N C([C@@H]([C@@H](O)C(=O)OC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)C1=CC=CC=C1 Chemical compound C([C@@H]([C@@H](O)C(=O)OC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)C1=CC=CC=C1 WBZSLZLPWSGTOM-BJKOFHAPSA-N 0.000 description 1
- CCPZLOXMCBWLKT-JEDNCBNOSA-N CC(C)([C@H](CO)N)SC.Cl Chemical compound CC(C)([C@H](CO)N)SC.Cl CCPZLOXMCBWLKT-JEDNCBNOSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- UEQZWWUKYVSLCP-UHFFFAOYSA-N Cl.C(C)N=C=NC(CC(C)N(C)C)=O Chemical compound Cl.C(C)N=C=NC(CC(C)N(C)C)=O UEQZWWUKYVSLCP-UHFFFAOYSA-N 0.000 description 1
- IGHSKJGOGTXZIL-UHFFFAOYSA-N Cl.C(C)N=C=NCCC(C)N(C)C Chemical compound Cl.C(C)N=C=NCCC(C)N(C)C IGHSKJGOGTXZIL-UHFFFAOYSA-N 0.000 description 1
- VLNQDWHIXNRLJF-VZXYPILPSA-N Cl.CNC(C[C@H]([C@H](CC1=CC=CC=C1)N)O)=O Chemical compound Cl.CNC(C[C@H]([C@H](CC1=CC=CC=C1)N)O)=O VLNQDWHIXNRLJF-VZXYPILPSA-N 0.000 description 1
- 102220489890 Cofilin-1_H47N_mutation Human genes 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102220519703 Cytosolic phospholipase A2 gamma_H44N_mutation Human genes 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical class C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000238558 Eucarida Species 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical class F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 206010023203 Joint destruction Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000000422 Matrix Metalloproteinase 3 Human genes 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- VIWZVFVJPXTXPA-UHFFFAOYSA-N N-(2-Carboxymethyl)-morpholine Chemical compound OC(=O)CN1CCOCC1 VIWZVFVJPXTXPA-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 241001181114 Neta Species 0.000 description 1
- HZHSTQCCUZICKQ-SYPWQXSBSA-N OC(N)C[C@@H](C)O Chemical compound OC(N)C[C@@H](C)O HZHSTQCCUZICKQ-SYPWQXSBSA-N 0.000 description 1
- NTXUXAYDAADYJZ-MNOVXSKESA-N O[C@H](C(=O)N)[C@H](C(=O)N)CCCCCCCCC Chemical compound O[C@H](C(=O)N)[C@H](C(=O)N)CCCCCCCCC NTXUXAYDAADYJZ-MNOVXSKESA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000006859 Swern oxidation reaction Methods 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- HNFXXKDUEBXQST-UHFFFAOYSA-N [O-2].[Al+3].[Rh+3] Chemical compound [O-2].[Al+3].[Rh+3] HNFXXKDUEBXQST-UHFFFAOYSA-N 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- PHENPABYBHPABM-UHFFFAOYSA-N acetic acid;octane Chemical compound CC(O)=O.CCCCCCCC PHENPABYBHPABM-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000005262 alkoxyamine group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 229940000489 arsenate Drugs 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 150000004792 aryl magnesium halides Chemical class 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000005885 boration reaction Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004623 carbolinyl group Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Natural products O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000005243 carbonyl alkyl group Chemical group 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000001721 carboxyacetyl group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical group 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical group [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 208000037516 chromosome inversion disease Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940076286 cupric acetate Drugs 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 229960004643 cupric oxide Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XXKOQQBKBHUATC-UHFFFAOYSA-N cyclohexylmethylcyclohexane Chemical compound C1CCCCC1CC1CCCCC1 XXKOQQBKBHUATC-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 239000012351 deprotecting agent Substances 0.000 description 1
- 238000005828 desilylation reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- OVVMHZRGSHTZDB-UHFFFAOYSA-N dibutylboron Chemical compound CCCC[B]CCCC OVVMHZRGSHTZDB-UHFFFAOYSA-N 0.000 description 1
- SYZWSSNHPZXGML-UHFFFAOYSA-N dichloromethane;oxolane Chemical compound ClCCl.C1CCOC1 SYZWSSNHPZXGML-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- XYVHRFVONMVDGK-QMMMGPOBSA-N dipropan-2-yl (2s)-2-hydroxybutanedioate Chemical compound CC(C)OC(=O)C[C@H](O)C(=O)OC(C)C XYVHRFVONMVDGK-QMMMGPOBSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- QGJJOACVGVBTHP-UHFFFAOYSA-N ethoxy-(2-ethoxy-2-oxoethyl)phosphinic acid Chemical compound CCOC(=O)CP(O)(=O)OCC QGJJOACVGVBTHP-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- AZLPEJUVWWGLHA-UHFFFAOYSA-N ethyl acetate;hexane;methanol Chemical compound OC.CCCCCC.CCOC(C)=O AZLPEJUVWWGLHA-UHFFFAOYSA-N 0.000 description 1
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 150000002301 glucosamine derivatives Chemical class 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 1
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000008011 inorganic excipient Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- NWYYWIJOWOLJNR-RXMQYKEDSA-N l-valinol Chemical compound CC(C)[C@H](N)CO NWYYWIJOWOLJNR-RXMQYKEDSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- CEAJFNBWKBTRQE-UHFFFAOYSA-N methanamine;methanol Chemical compound NC.OC CEAJFNBWKBTRQE-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- RHMQNXNXUZLEIY-UHFFFAOYSA-N methanol;2-propan-2-yloxypropane Chemical compound OC.CC(C)OC(C)C RHMQNXNXUZLEIY-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- RRIWSQXXBIFKQM-UHFFFAOYSA-N monomeric N-benzylcarbamic acid Natural products OC(=O)NCC1=CC=CC=C1 RRIWSQXXBIFKQM-UHFFFAOYSA-N 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BXGTVNLGPMZLAZ-UHFFFAOYSA-N n'-ethylmethanediimine;hydrochloride Chemical compound Cl.CCN=C=N BXGTVNLGPMZLAZ-UHFFFAOYSA-N 0.000 description 1
- CABYHZORCTZBOU-UHFFFAOYSA-N n,n-dimethylfuran-3-amine Chemical compound CN(C)C=1C=COC=1 CABYHZORCTZBOU-UHFFFAOYSA-N 0.000 description 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 description 1
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 1
- XEHMGFLMCFVFAO-UHFFFAOYSA-N n-[tert-butyl(dimethyl)silyl]hydroxylamine Chemical compound CC(C)(C)[Si](C)(C)NO XEHMGFLMCFVFAO-UHFFFAOYSA-N 0.000 description 1
- OCKPCBLVNKHBMX-UHFFFAOYSA-N n-butyl-benzene Natural products CCCCC1=CC=CC=C1 OCKPCBLVNKHBMX-UHFFFAOYSA-N 0.000 description 1
- 125000004998 naphthylethyl group Chemical group C1(=CC=CC2=CC=CC=C12)CC* 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical class CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 239000008012 organic excipient Substances 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 238000007248 oxidative elimination reaction Methods 0.000 description 1
- AIRCTMFFNKZQPN-UHFFFAOYSA-N oxidoaluminium Chemical compound [Al]=O AIRCTMFFNKZQPN-UHFFFAOYSA-N 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229930189471 penicacid Natural products 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960003857 proglumide Drugs 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- NGHMEZWZOZEZOH-UHFFFAOYSA-N silicic acid;hydrate Chemical compound O.O[Si](O)(O)O NGHMEZWZOZEZOH-UHFFFAOYSA-N 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 150000003388 sodium compounds Chemical class 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 108091007196 stromelysin Proteins 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- WPWXYQIMXTUMJB-UHFFFAOYSA-N tert-butyl 3-(aminomethyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC(CN)C1 WPWXYQIMXTUMJB-UHFFFAOYSA-N 0.000 description 1
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WJXKWIFHRZWPET-UHFFFAOYSA-N tert-butyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC(C)(C)C WJXKWIFHRZWPET-UHFFFAOYSA-N 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical class C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 238000007070 tosylation reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical class OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- YEIGUXGHHKAURB-VAMGGRTRSA-N viridin Chemical compound O=C1C2=C3CCC(=O)C3=CC=C2[C@@]2(C)[C@H](O)[C@H](OC)C(=O)C3=COC1=C23 YEIGUXGHHKAURB-VAMGGRTRSA-N 0.000 description 1
- 108010086097 viridin Proteins 0.000 description 1
- YEIGUXGHHKAURB-UHFFFAOYSA-N viridine Natural products O=C1C2=C3CCC(=O)C3=CC=C2C2(C)C(O)C(OC)C(=O)C3=COC1=C23 YEIGUXGHHKAURB-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- the present invention relates to a novel yarn having excellent matrix metallobrotinase inhibitory activity.
- the present invention relates to a hydroxamic acid derivative, an agent for inhibiting metastasis, invasion and growth of various cancer cells, and a therapeutic and prophylactic agent for osteoarthritis and rheumatoid arthritis, which contain the derivative as an active ingredient.
- Matrix meta-oral proteinase is an enzyme that degrades the protein components that make up connective tissue.
- Gelatinase which belongs to this group, degrades type IV collagen, a major component of the basement membrane. In the process of neovascularization and metastasis of cancer in cancer tissues, the expression of gelatinase is increased or activated. Therefore, it is said that gelatinase plays an important role in destroying the basement membrane of cells in normal tissues (Annua 1 Review of Cell Biology, vol. 9). , 541-573 (1993)).
- N 2 described in WO 94-02447 (4-Hydroxyamino-12- (R) -isobutyl-3- (S) -hydroxysuccinyl) —L-t-one-isocyanate-N 1 -Methylamide is undergoing clinical trials in Europe and the United States as an anticancer agent (Proceedings of American As soci at ion for cancer Research, vol. 37, 633 (1996)).
- the present inventors have conducted intensive studies on the synthesis of a derivative having excellent matrix metallobrotinase inhibitory activity and its pharmacological activity, and as a result, it has excellent enzyme inhibitory activity on matrix metallobulininase.
- the present inventors have found novel derivatives useful as agents for inhibiting metastasis, invasion and proliferation of various cancer cells, and as therapeutic and preventive agents for osteoarthritis and rheumatoid arthritis, and completed the present invention.
- the present invention relates to a novel hydroxamic acid derivative having excellent matrix meta-oral proteinase inhibitory activity, and an agent for inhibiting metastasis, invasion and growth of various cancer cells, and an osteoarthritis containing the derivative as an active ingredient. And a therapeutic and prophylactic agent for rheumatoid arthritis.
- the compound of the present invention has the general formula (1)
- R 1 is an alkyl group having 1 to 15 carbon atoms which may have a substituent
- the substituent is an alkyl group having 1 to 4 carbon atoms, an alkoxy group or a halogeno group having 1 to 4 carbon atoms
- the substituent is an alkyl group having 1 to 4 carbon atoms, an alkoxy group or a halogeno group having 1 to 4 carbon atoms
- An aralkyloxy group having 7 to i4 carbon atoms which may have a substituent (the substituent is an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms or a halogeno group) ,
- alkoxyalkoxy group having 2 to 8 carbon atoms which may have a substituent (the substituent is a halogeno group)
- R 2 represents a hydrogen atom, a hydroxy group or an aliphatic acyloxy port having 1 to 4 carbon atoms
- R 3 is an alkyl group having 1 to 6 carbon atoms which may have a substituent
- R 4 is a hydrogen atom
- An alkyl group having 1 to 4 carbon atoms which may have a substituent (the substituent is a hydroxy group, an alkoxy group having 1 to 4 carbon atoms, an aliphatic acyloxy group having 1 to 6 carbon atoms, C2-C5 alkoxyl-rubonyl group, C2-C5 alkyl-rubamyl group, C3-C9 dialkyl-rubamoyl group, or C2-C8 dialkylamino group
- R 5 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms
- R e is a hydrogen atom
- An aliphatic acyl group having 1 to 6 carbon atoms which may have a substituent (an amino group, a monoalkylamino group having 1 to 4 carbon atoms, a dialkylamino having 2 to 8 carbon atoms) Group, an alkoxycarbonyl group having 2 to 5 carbon atoms, a monocyclic or condensed heterocyclyl group having 5 to 10 atoms or a carboxy group)
- the substituent is an alkyl group having 1 to 4 carbon atoms, an alkoxycarbonylalkyl group having 3 to 9 carbon atoms, or a carboxy group having 2 to 5 carbon atoms.
- R 1 is an optionally substituted alkyl group having 1 to 7 carbon atoms
- R 2 is a hydrogen atom
- R 4 is 2 to 5 carbon atoms
- examples of the “alkyl group having 1 to 15 carbon atoms” of the “alkyl group having 1 to 15 carbon atoms which may have a substituent” for R 1 include, for example, Methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, tert-butyl, n-pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, n-hexyl, 1-ethylbutyl, 4-methylpentyl , 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3 —Dimethylbutyl, 2-ethylbuty
- R 1 s s is an integer having 1 to 15 carbon atoms which may have a substituent.
- the number of substitution is preferably 1 to 3, and more preferably 1.
- the “alkoxy group having 1 to 6 carbon atoms” is For example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, tert-butoxy, n-pentoxy, isopentoxy, 2-methylbutoxy, neopentoxy, n-hexyloxy, 4-methylpentoxy, 3-methylpentoxy, 2-methylpentoxy, 3,3-dimethylbutoxy, 2,2-dimethylbutoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2, 3-dimethylbutoxy group and the like, preferably those having 2 to 4 carbon atoms (especially ethoxy, isopropoxy and butoxy groups).
- the substituent is an aryl group having 6 to 10 carbon atoms which may have a substituent (the substituent may be an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, or a halogeno group).
- aryl groups such as phenyl and naphthyl; 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2-ethylphenyl, 3-bromophenyl, 4-ethylphenyl, 2- Butylphenyl, 3-pentylphenyl, 4-pentylphenyl, 3,5-dimethylphenyl, 2,5-dimethylphenyl, 2,6-dimethylphenyl, 2,4-dimethylphenyl, 3,5-dibutylphenyl , 2,5-dipentylphenyl, 2,6-diphenylpyruphenyl, 2,4-diphenylbiphenyl, 2,3,6-trimethylphenyl, 2,3,4-trimethylphenyl 2,3,4,5-trimethylphenyl, 2,5,6-trimethylphenyl, 2,4,6-trimethylphenyl.2,3,6-Tributylphenyl, 2,3,4-
- Alkoxy substituted aryl groups such as 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl Bromophenyl, 3,5-difluorophenyl, 2,5-difluorophenyl, 2,6-difluorophenyl, 2,4-difluorophenyl, 3,5-dibromophenyl, 2,5-dibromophenyl, 2, 6-dichlorophenyl, 2,4-dichlorophenyl, 2,3,6-trifluorophenyl, 2,3,4-trifluorophenyl, 3,4,5-trifluorophenyl, 2,5,6-triphenyl Fluorophenyl, 2,4,6-trifluorophenyl, 2,3,6-tribromophenyl,
- a phenyl group which may have a substituent (the number of substituents is preferably 1 to 3, and more preferably 1).
- phenyl Preferable are phenyl, 4-methylphenyl, 4-methoxyphenyl and 4-chlorophenyl (particularly 4-chlorophenyl), and the substituent "
- a good aryloxy group having 6 to 10 carbon atoms is, for example, phenyloxy.
- aryloxy groups such as naphthyloxy group; 2-methylphenyloxy, 3-methylphenyloxy, 4-methylphenyloxy, 2-ethylphenyloxy, 3-propylphenyloxy , 4-ethylphenyloxy, 2-butylphenyloxy, 3-pentylphenyloxy, 4-pentylphenyloxy, 3,5-dimethylphenyloxy, 2,5-dimethylphenyl Niloxy, 2,6-dimethylphenyloxy, 2,4-dimethylphenyloxy, 3,5-dibutylphenyloxy, 2,5-dipentylphenyloxy, 2,6-dibutyl biphenyloxy, 2,4-dipro Bilphenoxy, 2,3,6-trimethylphenyloxy, 2,3,4-trimethylphenyloxy, 3,4,5-trimethylphenyloxy, 2,5,6-trimethyl Limethylphenyloxy, 2,4,6-Trimethylphenyloxy, 2,3,6-Trimethylphenyloxy
- a phenyloxy group substituted with a methoxy or chloro group more preferably a phenyloxy, 4-methylphenyloxy, 4-methoxyphenyloxy or 4-cyclophenyloxy group.
- the substituent is an “aralkyloxy group having 7 to 14 carbon atoms which may have a substituent (the substituent is an alkyl group having 1 to 4 carbon atoms, and an alkyl group having 1 to 4 carbon atoms, An alkoxy group or a halogeno group)] are benzyloxy, ⁇ -naphthylmethyloxy, / 3-naphthylmethyloxy, 2-methylbenzyloxy, 3-methylbenzyloxy, 4-methylbenzyloxy, 2,4 , 6-trimethylbenzyloxy, 3,4,5-trimethylbenzyloxy, 2-methoxybenzyloxy, 3-methoxybenzyloxy, 4-methoxybenzyloxy, 3 , 4-dimethoxybenzyloxy, 2-chlorobenz
- the substituent “alkoxyalkoxy group having 2 to 8 carbon atoms which may have a substituent (the substituent is an octalogeno group)” J is methoxymethoxy, ethoxyethoxy, ethoxymethyl or the like.
- Toxi isopropoxymethoxy, fluoromethoxime, (2,2,2-trifluoroethoxy) methoxy, trifluoromethoxime, chloromethoxime, promomethoxime, odomethoxime
- Examples include toxic, methoxybutoxy and butoxybutoxy groups, preferably those having 3 to 6 carbon atoms.
- Ri more preferably, Etokishe Bok carboxymethyl, I Sopurobokishe Bok alkoxy and (2, 2, 2-Torifuruoroe Bok carboxymethyl) a main Bok alkoxy group,
- R 1 ⁇ an alkyl group having 1 to 15 carbon atoms which may have a substituent '' as a whole,
- alkyl group having 1 to 6 carbon atoms substituted with an alkoxy group having 2 to 6 carbon atoms, methyl, methoxy or methyl group Alkyl groups having 1 to 6 carbon atoms substituted with a good phenyl group, alkyl groups having 1 to 6 carbon atoms substituted with a cycloalkyl group having 4 to 6 carbon atoms, and alkoxy groups having 4 to 6 carbon atoms
- examples of the “aliphatic acyloxy group having 1 to 6 carbon atoms” for R 2 include, for example, formyloxy, acetoxy, propionyloxy, petyriloxy, pentanoyloxy group and the like. Is an acetate group.
- alkyl group having 1 to 6 carbon atoms of the “alkyl group having 1 to 6 carbon atoms which may have a substituent” for R 3 , for example, methyl, Ethyl, ⁇ -propyl, isopropyl, ⁇ -butyl, isobutyl, s-butyl, tert-butyl, n-pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, n-hexyl, 1-ethylbutyl, 4 -Methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3- Dimethylbutyl, 2-ethylbutyl group
- examples of the “C 1 to C 4 alkoxy group” as a substituent in the “optionally substituted C 1 to C 6 alkyl group” for R 3 include, for example, , Methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, s-butoxy, tert-butoxy groups, and is preferably a methoxy group.
- examples of the “to 4 alkylthio groups” include methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, s-butylthio, and tert-butyl. And preferably a methylthio and an ethylthio group, more preferably a methylthio group, '
- substituents "aliphatic acyloxy group having 1 to 6 carbon atoms” include, for example, formyloxy, acetoxy, propionyloxy, butyryloxy, pentanoyloxy, and the like.
- An ethoxy group, and the substituent, "an aryl group having 6 to 10 carbon atoms which may have a substituent (the substituent is an alkyl group having 1 to 4 carbon atoms, A hydroxy group, an aliphatic alkoxy group having 1 to 4 carbon atoms, an alkoxy group or a halogeno group having 1 to 4 carbon atoms)), for example, an aryl group such as a phenyl or naphthyl group; Tylphenyl, 3-methylphenyl, 4-methylphenyl, 2-ethylphenyl, 3-propylphenyl, 4-ethylphenyl, 2-butylphenyl, 3-pentylphenyl, 4-pentylphenyl Ny
- Fluorophenyl 3,5-dibromophenyl, 2,5-dibromophenyl, 2,6-dichlorophenyl, 2,4-dichlorophenyl, 2,3,6-trifluorophenyl, 2,3,4 — Trifluorophenyl, 3,4,5—trifluorophenyl, 2,5,6—trifluorophenyl, 2,4,6—trifluorophenyl, 2,3,6—tribromophenyl, 2,3,4 — Tribromophenyl, 3,4,5-tribromophenyl, 2,5,6-trichlorophenyl, 2,4,6-trichloromethylphenyl, 1-fluoro-2-naphthyl, 2-fluoro-1-naphthyl, 3-Fluoro-1-naphthyl, 1-chloro- 2-naphthyl, 2-chloro-1-naphthyl, 3-bromo-1-naph
- a furyl Preferable are a furyl, phenyl and benzofuranyl group, more preferably a furyl group, and the substituent "the cycloalkyl group having 3 to 8 carbon atoms" is , Cyclobutyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl groups, preferably having 4 to 6 carbon atoms (especially cyclohexyl group),
- an alkyl group having 1 to 6 carbon atoms which may have a substituent” for R 3 is preferably an unsubstituted alkyl group having 1 to 4 carbon atoms, methylthio or ethylthio.
- an alkyl group having 1 to 4 carbon atoms substituted with a hydroxy group and an alkyl group having 1 to 4 carbon atoms substituted with an acetyl group is preferably an unsubstituted alkyl group having 1 to 4 carbon atoms, methylthio or ethylthio.
- Isobrovir tert-butyl, 1-methylpropyl, 2-methylpropyl, 1-methylthio-1-methylethyl, cyclohexylmethyl, benzyl, hydroxymethyl and acetomethyl groups, most preferably tert-butyl.
- Le, 1 Mechiruchio one 1 Mechiruechiru, is cyclohexylmethyl cyclohexylene and benzyl groups (especially tert- butyl and downy Njiru group)
- examples of the “alkoxycarbonyl group having 2 to 5 carbon atoms” include methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl /
- examples of the “alkyl group having 1 to 4 carbon atoms” of the “alkyl group having 1 to 4 carbon atoms which may have a substituent” for R 4 include methyl, Examples include ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and tert-butyl groups, preferably methyl, ethyl and propyl groups, and more preferably methyl and ethyl groups.
- examples of the “C 1 to C 4 alkoxy group” which is a substituent in the “optionally substituted C 1 to C 4 alkyl group” include: Examples include methoxy, ethoxy, propoxy, isobroboxy, butoxy, isobutoxy, s-butoxy and tert-butoxy groups, and are preferably methoxy and ethoxy groups, and the substituents "1 to 1 carbon atoms"
- examples of the "six aliphatic radicals” include, for example, acetate, propionyloxy, butyryloxy and pentanoyl radicals, preferably those having 2 to 3 carbon atoms (ie, Acetoxy and propionyloxy groups), and more preferably an acetoxy group, and the substituent “an alkoxycarbonyl group having 2 to 5 carbon atoms j” Examples thereof include methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, and the like.
- alkyl C2-5 alkyl group examples include methylcarbamoyl, ethylcarbamoyl, propylcarbamoyl, isopropylcarbamine, butylcarbamoyl, isobutylcarbamoyl, s-butylcarbamoyl and tert-butylcarbamoyl groups.
- Rucarbamoyl and ethylcarbamoyl groups are preferably a methylcarbamolyl group
- the substituent “dialkyl-powered rubamoyl group having 3 to 9 carbon atoms” includes, for example, dimethylcarbamoyl, methyl (ethyl) Power rubamoyl, getylcarbamoyl, dipropyl power rubamoyl, methyl (propyl) power rubamoyl, diisoprovil power rubamoyl, dibutyl carbamoyl, diisobutyl carbamoyl, di (s-butyl) power rubamoyl, di (tert-butyl) power rubamoyl group, etc.
- a dimethylcarbamoyl group and a dimethylcarbamoyl group, more preferably a dimethylcarbamoyl group, and the substituent “dialkylamino group having 2 to 8 carbon atoms” is dimethylamino.
- an alkyl group having 1 to 4 carbon atoms which may have a substituent” for R 4 is preferably an unsubstituted alkyl group having 1 to 4 carbon atoms or a hydroxy group.
- alkyl groups having 1 to 4 carbon atoms substituted with hydroxy and hydroxy groups and alkyl groups having 1 to 4 carbon atoms substituted with dimethylamino and acetooxy groups (especially methyl, ethyl, hydroxyme Le, 2 - hydroxy E Chill, 3 - hydroxypropionic building, Ethoxycarbonylmethyl, acetoxymethyl, 2-acetoxitytyl, 3-acetooxypropyl, methylcarbamoylmethyl, dimethylcarbamoylmethyl, dimethylaminoethyl, 3-dimethylamino-2-hydroxypropyl and 3-dimethylamino-2-ace And more preferably an alkyl group having 1 to 4 carbon atoms substituted with a hydroxy group or an alkyl group having 1 to 4 carbon atoms substituted with an acetyl group (especially, phenyl group).
- the “alkyl group having 1 to 4 carbon atoms” for R 5 includes, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl and tert-butyl groups And preferably a methyl group.
- aliphatic Ashiru group having 1 to 6 carbon atoms in “optionally aliphatic Ashiru group which may having 1 to 6 carbon atoms have a substituent” for R e is, for example, And formyl, acetyl, propionyl, butyryl, isoptyryl, pentanoyl, and vivaloyl groups, preferably those having 2 to 3 carbon atoms (that is, acetyl and propionyl groups), and more preferably acetyl Group.
- a monoalkylamino group having 1 to 4 carbon atoms which is a substituent of “an aliphatic acryl group having 1 to 6 carbon atoms which may have a substituent” for R 6
- Examples thereof include a methylamino, ethylamino, propylamino, isobroviramino, butylamino, isobutylamino, s-butylamino and tert-butylamino group, preferably a methylamino group, and the substituent, "C2 having 2 carbon atoms" Or 8 dialkylamino groups '' , Dimethylamino, methyl (ethyl) amino, getylamino, methyl (propyl) amino, dibutylamino, diisopropylamino, diisopropylamino, dibutylamino, disobutylamino, di (s-butyl) amino, di (tert-butyl)
- alkoxycarbonyl group having 2 to 5 carbon atoms is, for example, Toxoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isobroboxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, s-butoxycarbonyl and tert-butoxycarbonyl groups, preferably ethoxycarbonyl group, Is "5 to 15 atoms Ring or heterocyclyl groups condensed (heteroatom nitrogen contained in the ring, oxygen or sulfur atom) as the "aforementioned alkyl" substituent a good number 1 to 6 carbon atoms which may have R 3
- the same substituents as those described above as the substituent of the ⁇ group '' can be mentioned, and are preferably morpholino and pyrrolidino groups,
- R 6 “optionally substituted aliphatic alkyl group having 1 to 6 carbon atoms” As a whole, preferred are acetyl, bropionyl, dimethylaminoacetyl, carboxyacetyl, and 3-carboxybutionyl group. And more preferably an acetyl and propionyl group (especially an acetyl group).
- examples of the “alkyl group having 1 to 4 carbon atoms” which is a substituent of the “optionally substituted rubamoyl group” of R 6 include methyl, ethyl, n —Propyl, isopropyl, n-butyl, isobutyl, s-butyl and tert-butyl groups, preferably methyl and ethyl groups, and the substituent “alkoxycarbonylalkyl having 3 to 9 carbon atoms” Examples of the group include methoxycarbonylmethyl, ethoxycarbonylmethyl, methoxycarbonylethyl, ethoxycarbonylethyl, propoxycarbonylpropyl, butoxycarbonylbutyl, and the like.
- the benzyl group include carboxymethyl, 2-carboxyethyl, 3-carboxybutyl pill, 2-carboxy-1-methylethyl, 4-carboxybutyl, 3-carboxy-1-methylpropyl, and 3-carboxy-2-methylpropyl.
- carboxymethyl, 2-carboxyethyl, 3-carboxypropyl, and 4-carboxybutyl groups are examples of the substituent is a carboxyalkyl group having 2 to 5 carbon atoms.
- the benzyl group include carboxymethyl, 2-carboxyethyl, 3-carboxybutyl pill, 2-carboxy-1-methylethyl, 4-carboxybutyl, 3-carboxy-1-methylpropyl, and 3-carboxy-2-methylpropyl.
- R 1 is preferably a non-substituted alkyl group having 4 to 10 carbon atoms, or a carbon atom having 1 to 6 carbon atoms substituted with an alkoxy group having 2 to 6 carbon atoms.
- alkyl group having 1 to 6 carbon atoms a cycloalkyl group having 1 to 6 carbon atoms, and a cycloalkyl group having 4 to 6 carbon atoms, which may be substituted with one methyl, methoxy, Substituted alkyl group having 1 to 6 carbon atoms and 4 to 4 carbon atoms -it,
- alkyl group having 1 to 6 carbon atoms substituted with 6 alkoxyalkoxy groups more preferably octyl, 7-methyloctyl, nonyl, 8-methylnonyl, phenylpropyl, 4-methylphenyl Propyl, 4-methoxyphenylphenyl, 4-cyclophenylphenyl, cyclohexylmethyl, cyclohexylpropyl, 6-ethoxyhexyl, 6-isopropoxyhexyl and 4-butoxybutyl, more preferably Is a nonyl, 7-methyloctyl and 4-cyclophenylphenylpropyl group.
- R 2 as a whole is preferably a hydrogen atom, a hydroxy or an acetyl group, and more preferably a hydrogen atom or a hydroxy group.
- R 3 as a whole is preferably an unsubstituted alkyl group having 1 to 4 carbon atoms or an alkyl group having 1 to 4 carbon atoms substituted with one methylthio or ethylthio group.
- R 4 as a whole is preferably a hydrogen atom, an unsubstituted alkyl group having 1 to 4 carbon atoms, or an alkyl group having 1 to 4 carbon atoms substituted with one hydroxy group.
- 1 to 4 carbon atoms substituted with 1 dimethylcarbamoyl group 1 to 4 carbon atoms substituted with 1 dimethylcarbamoyl group, and 1 carbon atom substituted with 1 dimethylamino group
- R 5 is a hydrogen atom.
- R 6 is a hydrogen atom and an unsubstituted aliphatic acyl group having 2 to 3 carbon atoms, a dialkylamino group having 1 to 2 carbon atoms or 1 Aliphatic carbonyl group having 2 to 3 carbon atoms, more preferably a hydrogen atom, acetyl and propionyl group, most preferably a hydrogen atom and acetyl group .
- preferred are those represented by the formula (1):
- R 1 is an unsubstituted alkyl group having 4 to 10 carbon atoms, an alkyl group having 1 to 6 carbon atoms substituted by an alkoxy group having 2 to 6 carbon atoms, methyl, methoxy or Or an alkyl group having 1 to 6 carbon atoms substituted by a phenyl group which may be substituted by a chloro group, or an alkyl group having 1 to 6 carbon atoms substituted by a cycloalkyl group having 4 to 6 carbon atoms A compound having 1 to 6 carbon atoms, which is substituted by a group or an alkoxyalkoxy group having 4 to 6 carbon atoms,
- R 1 is octyl, 7-methyloctyl, nonyl, 8-methylnonyl, Phenylpropyl, 4-methylphenylpropyl, 4-methoxyphenylpropyl, 4-chlorophenylpropyl, cyclohexylmethyl, cyclohexylpropyl, 6-ethoxyhexyl, 6-isopropoxyhexyl Or a compound that is a 4_butoxybutyl group,
- R 2 is a hydrogen atom, a hydroxy or acetyl group
- R 2 force a compound which is a hydrogen atom or a hydroxy group
- R 3 is an unsubstituted alkyl group having 1 to 4 carbon atoms, an alkyl group having 1 to 4 carbon atoms substituted with a methylthio or ethylthio group, or a cycloalkyl group having 4 to 6 carbon atoms.
- a substituted or unsubstituted phenyl-substituted phenyl group-substituted alkyl group having 1 to 4 carbon atoms, a hydroxy-substituted alkyl group having 1 to 4 carbon atoms, or an acetoxy group A compound which is a substituted alkyl group having 1 to 4 carbon atoms,
- R 3 force A compound that is an isobrovir, tert-butyl, 1-methylbrovir, 2-methylbutyl, 1-methylthio-11-methylethyl, cyclohexylmethyl, benzyl, hydroxymethyl or acetyloxymethyl group,
- R 3 compound which is tert-butyl, 1-methylthio-1-methylethyl, cyclohexylmethyl or benzyl group, 10) a compound that is an R 3 tert-butyl or benzyl group;
- R 4 is a hydrogen atom, an unsubstituted alkyl group having 1 to 4 carbon atoms, an alkyl group having 1 to 4 carbon atoms substituted with a hydroxy group, or a carbon number substituted with an ethoxycarbonyl group 1 to 4 alkyl groups, 1 to 4 carbon atoms substituted with an acetyloxy group, 1 to 4 carbon atoms substituted with a methylcarbamoyl group, and carbon substituted with a dimethylcarbamoyl group
- R 4 force A compound which is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms substituted with a hydroxy group or an acetoxy group,
- R 5 force A compound that is a hydrogen atom
- R 6 force Hydrogen atom or unsubstituted aliphatic carbon group having 2 to 3 carbon atoms, carbon atom substituted by dialkylamino group having 2 to 4 carbon atoms or carboxy group A compound that is 2 to 3 aliphatic acyl groups,
- R 6 is a hydrogen atom, acetyl or propionyl group
- R 6 force A compound which is a hydrogen atom or an acetyl group
- R 1 is an unsubstituted alkyl group having 4 to 10 carbon atoms, an alkyl group having 1 to 6 carbon atoms substituted with an alkoxy group having 2 to 6 carbon atoms, methyl, methoxy or chloro.
- R 2 force, a hydrogen atom, a hydroxy or acetyl group
- R 3 is substituted with an unsubstituted alkyl group having 1 to 4 carbon atoms, an alkyl group having 1 to 4 carbon atoms substituted with a methylthio or ethylthio group, or a cycloalkyl group having 4 to 6 carbon atoms Substituted with methyl or ethyl, unsubstituted phenyl-substituted alkyl group having 1 to 4 carbon atoms, hydroxy-substituted alkyl group having 1 to 4 carbon atoms or substituted with acetyl group Alkyl group having 1 to 4 carbon atoms,
- R 4 a hydrogen atom, an unsubstituted alkyl group having 1 to 4 carbon atoms, an alkyl group having 1 to 4 carbon atoms substituted with a hydroxy group, and an ethoxycarbonyl group Alkyl group having 1 to 4 carbon atoms, alkyl group having 1 to 4 carbon atoms substituted with acetooxy group, alkyl group having 1 to 4 carbon atoms substituted with methylcarbamoyl group, substituted with dimethylcarbamoyl group An alkyl group having 1 to 4 carbon atoms, an alkyl group having 1 to 4 carbon atoms substituted with a dimethylamino group, an alkyl group having 1 to 4 carbon atoms or a dimethylamino group substituted with a dimethylamino group and a hydroxy group, and An alkyl group having 1 to 4 carbon atoms, which is substituted with an acetoxy group;
- R 5 force 5 hydrogen atom
- R 6 is a hydrogen atom or an unsubstituted aliphatic C2 to C3 aliphatic acyl group, a C2 to C3 aliphatic C2 to C4 dialkylamino group or a carboxy group A compound that is
- R 2 is a hydrogen atom or a hydroxy group
- R 3 is tert-butyl, 1-methylthio-1-methylethyl, cyclohexylmethyl or benzyl group,
- R 4 is a hydrogen atom
- R 5 is a hydrogen atom
- R 6 is a hydrogen atom or an acetyl group
- R 1 is a nonyl or 3- (4-monophenyl) propyl group
- R 2 is a hydrogen atom or a hydroxy group
- R 3 is a tert-butyl or benzyl group
- R 4 is a hydrogen atom
- R 5 is a hydrogen atom
- a compound wherein R e is a hydrogen atom or an acetyl group Can be given.
- the compound (1) of the present invention has a carboxy group, it can be converted into a salt.
- Such salts are preferably alkali metal salts such as sodium salt, potassium salt, lithium salt, alkaline earth metal salts such as calcium salt, magnesium salt, aluminum salt, iron salt, zinc salt, Metal salts such as copper salts, 2'-sokel salts, and cobalt salts; inorganic salts such as ammonium salts, octylamine salts, dibenzylamine salts, morpholine salts, glucosamine salts, phenylglycine alkyl ester salts, ethylenediamine salts, N —Methylglucamine salt, guanidine salt, getylamine salt, triethylamine salt, dicyclohexylamine salt, N, N '—dibenzylethylenediamine salt, chlorobrocaine salt, pro-forcein salt, diethanolamine salt, N-benzyldiene Tilamine salt, biradine salt, tetramethylammonium Salts and amine salts such as organic salt
- Such salts preferably include hydrofluorides, hydrochlorides, hydrobromides, hydrohalides such as hydroiodide, nitrates, perchlorates, sulfates, and the like.
- Inorganic acid salts such as phosphates; lower alkane sulfonates such as methanesulfonate, trifluoromethanesulfonate, and ethanesulfonate; benzenesulfonates; and salts such as P-toluenesulfonate.
- the compound (1) of the present invention absorbs moisture when left in the air. In some cases, water may be collected and adsorbed water may be formed, or may be hydrated. Such a hydrate is also included in the present invention. Furthermore, the compound (1) of the present invention has an asymmetric carbon atom in the molecule, and there are stereoisomers each of which is in the R or S configuration. Any of the mixtures are included in the present invention.
- examples of the compound having a suitable configuration include those of the following formula (wherein, R 1 , R 2 , R 3 , R 4 , R s and R s are Same meaning as above).
- Me represents a methyl group
- Et represents an ethyl group
- Pr represents a bromo group
- ⁇ Pr represents an isopropyl group
- Bu represents a butyl group
- ⁇ Bu represents isobutyl group.
- Bu represents a t-butyl group
- Bn represents a benzyl group
- Ac represents an acetyl group
- ct represents an octyl group
- Non represents a nonyl group
- HX represents cyclo.
- Ph represents a hexyl group
- Ph represents a phenyl group
- Mor represents a morpholino group
- T hi represents a chelyl group.
- Non H tBu CH 2 0Me HH preferred ones are 8, 9, 10, 10, 11, 12, 13, 16, 17, 17, 20, 21, 28, 29, 66, 67, 70, 7 1, 74, 75, 102, 107, 108, 109, 110, 167, 168, 171, 1 72, 1 75, 1 76, 30 1, 302, 305, 306, 307, 308 and 313, and more preferably,
- the hydroxamic acid derivative of the present invention can be produced by the method described in the following! (3)
- R ′, R 2 , R 3 , R 4 , R 5 and R 6 have the same meanings as described above, and R 6a is an optionally substituted C 2-5 aliphatic acyl group.
- the substituent may be an amino group which may be protected, an alkylamino group having 1 to 4 carbon atoms, a dialkylamino group having 2 to 8 carbon atoms, or an alkoxycarbonyl group having 2 to 5 carbon atoms.
- R 7 represents a “silyl-type” protecting group (preferably a tert-butyldimethylsilyl group) or a benzyl-type protecting group (preferably a benzyl group), and R 8 represents the same group as R 7.
- R 13 , R 14 and R 15 are the same or different and represent an alkyl group having 1 to 4 carbon atoms
- R 16 represents an aliphatic or aromatic acyl group
- R 17 represents an alkyl group
- R ie represents a fat aliphatic or aromatic Ashiru radical
- n represents 1 to 4 integers
- t B u represents a t-Bed butyl group
- i P r is Indicates an isopropyl group
- TBS represents a t one heptyl dimethyl silyl group
- T s is. Below showing the p- toluenesulfonyl group, will be described for each step.
- the condensation is carried out by a conventional method, for example, an azide method, an active ester method, a mixed acid anhydride method or a condensation method.
- compound (2) is reacted with hydrazine in an inert solvent (eg, dimethylformamide) at around room temperature, and then the produced acid hydrazide is reacted with a nitrite compound to convert the compound to an azide compound. After that, it is performed by treating with an amine compound (3).
- an inert solvent eg, dimethylformamide
- nitrite compound to be used examples include an alkali metal nitrite such as sodium nitrite or an alkyl nitrite such as isoamyl nitrite.
- the reaction is preferably carried out in an inert solvent, and examples of the solvent used include amides such as dimethylformamide and dimethylacetamide, sulfoxides such as dimethylsulfoxide, and N-methylvilolid. And pyrrolidones such as don.
- the two steps of the present method are usually performed in one reaction solution, and the reaction temperature is ⁇ 50 to 0 ° C. in the first stage, and 110 ° C. to 10 ° C. in the second stage.
- the time required for the reaction is 5 minutes to 1 hour in the first stage and 10 hours to 5 days in the second stage.
- the active ester method is carried out by reacting the compound (2) with an active esterifying agent to produce an active ester, and then reacting it with the amine compound (3).
- Both reactions are preferably carried out in an inert solvent and the solvents used are, for example, halogenated hydrocarbons such as methylene chloride, chloroform, ethers and tetrahydrofuran. Examples thereof include amides such as ethers, dimethylformamide and dimethylacetamide, and nitriles such as acetonitrile.
- active esterifying agent examples include N-hydroxysuccinimide, 1-hydroxybenzotriazole, N-hydroxy-5-norbornene and the like. Shi-
- N-hydroxy compounds such as 2,3-dicarboximide and disulfide compounds such as dipyridyl disulfide.
- the active esterification reaction is carried out by dicyclohexylcarbodiimide or triphenylphosphine. It is suitably carried out in the presence of a condensing agent such as
- an organic amine such as triethylamine, N-methylmorpholine, or dimethylaminopyridine may be used as the base catalyst.
- the reaction temperature is between 110 ° C. and 100 ° C. for the active esterification reaction, and is around room temperature for the reaction of the active ester compound with the amine (3). 30 minutes to 80 hours.
- the mixed acid anhydride method is carried out by producing a mixed acid anhydride of the compound (2) and reacting the mixed acid anhydride with an amine.
- the reaction for producing the mixed acid anhydride is carried out in an inert solvent (for example, the above-mentioned halogenated hydrocarbons, amides, ethers (preferably tetrahydrofuran)) in a mixed acid dehydrating agent such as chlorocarbonic acid.
- a mixed acid dehydrating agent such as chlorocarbonic acid.
- Ethyl, lower alkanol halides such as pivaloyl chloride or lower (C, -C 4) alkyl halides such as isobutyl chlorocarbonate or lower alkyls or diarylcyanos such as getylcyanophosphate, diphenylcyanophosphate. This can be achieved by reacting compound (2) with phosphoric acid or the like.
- the reaction is preferably carried out in the presence of an organic amine such as triethylamine, N-methylmorpholine, dimethylaminoviridine, pyridine, and the reaction temperature is 120 to 50, and the time required for the reaction is 30. Minutes to 20 hours.
- the reaction of the mixed anhydride with the amine (3) is preferably carried out in an inert solvent (for example, the amides or ethers described above) in the presence of the organic amine!
- the reaction is performed at a temperature of 0 to 80 ° C., and the time required for the reaction is 1 hour to 24 hours.
- This reaction is also performed in the presence of compound (2), compound (3) and a mixed acid anhydride-forming agent.
- the compound (2) and the amine (3) can be obtained by diluting the compound (2) in the presence of a condensing agent such as dicyclohexylcarbodiimide, carbonyldiimidazole, ⁇ -methyl-2-chloro-pyridinyl-m-zidotriethylamine. It is done by reacting directly. This reaction is carried out in the same manner as the above-mentioned reaction for producing an active ester.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insoluble matter is present, it is removed by filtration.
- Such an organic solvent immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound can be obtained by a conventional method, for example, recrystallization, reprecipitation, or a method usually used for separation and purification of organic compounds, for example, silica gel, alumina, magnesium-silica gel type florisil Column chromatography using a simple carrier; Sephadex LH-20 (Pharmacia), Amber-Light XAD-11 (Rohm and Haas), Diaion HP-20 ( Synthesis such as partition column chromatography using a carrier such as Mitsubishi Kasei Co., Ltd.
- a conventional method for example, recrystallization, reprecipitation, or a method usually used for separation and purification of organic compounds, for example, silica gel, alumina, magnesium-silica gel type florisil Column chromatography using a simple carrier; Sephadex LH-20 (Pharmacia), Amber-Light XAD-11 (Rohm and Haas), Diaion HP-20 ( Synthesis such as partition column chromatography using a carrier such as Mitsubishi Kasei Co.
- This step is a step of condensing compound (5) and compound (3) in an inert solvent to produce compound (6).
- This step can be performed in the same manner as in the first step.
- This step is a step of producing compound (8) by condensing compound (2) and compound (7) in an inert solvent. This step can be performed in the same manner as in the first step.
- This step is performed when R 7 is a silyl-type protecting group.
- the acid used is an organic acid such as acetic acid, methanesulfonic acid, para-toluenesulfonic acid, trifluoroacetic acid, or trifluoromethanesulfonic acid, or an inorganic acid such as hydrochloric acid, and preferably trifluoroacetic acid.
- the solvent to be used is not particularly limited as long as it does not hinder the reaction and dissolves the starting material to some extent, but is preferably a halogenated hydrocarbon such as methylene chloride or chloroform.
- Ethers such as tyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethyloxetane and diethylene glycol dimethyl ether; And organic solvents and mixed solvents thereof.
- Methylene chloride is preferred.
- the reaction temperature and the reaction time are not particularly limited, but are usually 0 to 100 (preferably 10 ° C. to 30 ° C.) and 1 to 72 hours (preferably 1 to 24 hours). Time) Implemented.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration. Add an organic solvent that is immiscible with water and wash with water etc.
- the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- This step is a step of condensing compound (5) and compound (7) in an inert solvent to produce compound (10).
- This step can be performed in the same manner as in the first step.
- this step in an inert solvent, with an acid to remove the isopropylidene group and the protective group represented by R 7 of the compound (10) is a step for preparing a compound (9).
- This step is performed when R 7 is a silyl-type protecting group.
- This step can be performed in the same manner as in the fourth step.
- acetic acid is used as the acid
- a mixed solution of tetrahydrofuran and water is used as the solvent.
- This step is a step of removing the isopropylidene group of compound (10) using an acid in an inert solvent to produce compound (6a).
- This step is performed when R 7 is a benzyl-type protecting group.
- This step can be performed in the same manner as in the sixth step.
- This step is a step of producing a compound (9) by removing the t-butyl group of the compound (4) using an acid in an inert solvent.
- This step can be performed in the same manner as in the fourth step.
- This step can be performed in the same manner as in the first step. 6?
- R 8 is a silyl-type protecting group, the ability to carry out in the same manner as in the fourth step.
- hydrochloric acid is used as the acid
- a mixed solvent of dioxane and water is used as the solvent.
- R 8 is a benzyl-type protecting group
- a method of removing by contacting with a reducing agent in a solvent is generally suitable.
- the solvent used is not particularly limited as long as it does not take part in the reaction, but includes alcohols such as methanol, ethanol and isopropanol, ethers such as getyl ether, tetrahydrofuran and dioxane, toluene, benzene, Aromatic hydrocarbons such as xylene, aliphatic hydrocarbons such as hexane and cyclohexane, esters such as ethyl acetate and propyl acetate, formamide, dimethylformamide, dimethylacetamide, Amides such as N-methyl-2-virolidone and hexamethyl phosphorotriamide, fatty acids such as formic acid and acetic acid, water, and a mixed solvent thereof are more preferable, and alcohol is more preferable, and alcohol is more preferable, and alcohol
- the catalyst to be used is not particularly limited as long as it is usually used in a catalytic reduction reaction, but is preferably palladium carbon, palladium black, Raney nickel, platinum oxide, platinum black, palladium Aluminum monoxide, rhodium aluminum monoxide, triphenylphosphine-rhodium chloride, and palladium-barium sulfate are used, preferably palladium-aluminum oxide.
- the pressure is not particularly limited, but it is usually 1 to 10 atm.
- the reaction temperature and reaction time vary depending on the starting material, solvent and type of catalyst, but are usually 0. C to 100 (preferably 20 to 5 CTC), 5 minutes to 48 hours (preferably 30 minutes to 10 hours).
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.For example, after removing the reduction catalyst by filtration, the solvent is distilled off if necessary, and the mixture is mixed with water such as ethyl acetate. An organic solvent containing no target compound is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound may be subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separating and purifying an organic compound, for example, the method described in the first step described above. Can be.
- Suitable solvents used are ethers such as getyl ether and tetrahydrofuran; hydrocarbons such as methylene chloride and chloroform; and amides such as dimethylformamide.
- organic amines such as pyridine, dimethylaminopyridine, N-methylmorpholine, and triethylamine are suitable.
- the reaction temperature is usually from 0 ° C. to room temperature, and the reaction time is usually from 30 minutes to 1 day, depending on the starting material, solvent, base and the like used.
- ethers such as Jethyl ether and tetrahydrofuran
- hydrocarbons such as methylene chloride and chloroform
- amides such as dimethylformamide
- Suitable bases used are organic amines such as pyridine, dimethylamino pyridine, N-methylmorpholine and triethylamine.
- the reaction temperature is usually from 0 to room temperature, and the reaction time is usually from 30 minutes to 1 day, depending on the starting material, solvent, base and the like used.
- R e when R 6a is a carbamoyl group R 6a when R 6a is a carbamoyl group.
- NCO R 6 represents the portion of Rea excluding the carbonyl group
- the solvent to be used aromatic hydrocarbons such as benzene and toluene are preferable, and pyridine and triethylamine are used as bases.
- the reaction temperature is usually from room temperature to 60, and the reaction time is from 30 minutes to 3 days.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration.
- a water-immiscible organic solvent such as that described above is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be performed by a method commonly used for separating and purifying an organic compound, for example, the method described in the first step.
- This step is a step of producing a compound (14) by removing the t-butyl group of the compound (13) using an acid in an inert solvent.
- This step can be performed in the same manner as in the fourth step.
- This step can be performed in the same manner as in the eighth step.
- This step is a step of removing the protecting group represented by R 8 of compound (15) in an inert solvent to produce the target compound (lb) of the present invention.
- This step can be performed in the same manner as in the ninth step.
- a step for preparing the object compound (1 a) of the present invention in an inert solvent in the presence of a base to remove the coercive Mamorumoto represented by R ea compound (lb), a step for preparing the object compound (1 a) of the present invention.
- the base used is not particularly limited as long as it does not affect the other parts of the compound, but is preferably a metal alkoxide such as sodium methoxide; sodium carbonate, carbon dioxide Alkali metal carbonates such as lime and lithium carbonate; alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, lithium hydroxide, barium hydroxide or ammonia water, ammonia such as concentrated ammonia-methanol , But are preferably sodium carbonate and potassium carbonate.
- the solvent to be used is not particularly limited as long as it is used in a usual hydrolysis reaction.
- organic solvents such as alcohols and mixed solvents of water and the above-mentioned organic solvents, and more preferred are alcohols (particularly methanol).
- reaction temperature and reaction time vary depending on the starting material, the solvent, the base used, and the like, and are not particularly limited.However, in order to suppress a side reaction, the reaction is usually performed at 0 to 150 ° C (preferably at 20 to 150 ° C). Performed at 30 ° 0 for 1 to 24 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration, and then ethyl acetate is added.
- Such an organic solvent immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- This step is a step of removing the isopropylidene group of compound (6) using an acid in an inert solvent to produce compound (11).
- the compound (1 1) by reacting Arukokishiamin R a 0 NH 2, is a step for preparing Compound (1-6).
- This step can be performed in the same manner as in the eighth step.
- the compound (1 1 a) by reacting an alkoxyamine R beta ONH 2, is a step for preparing a compound (16 a).
- This step can be performed in the same manner as in the eighth step.
- R 2 is a benzyl-type protecting group.
- This step is a step for producing the target compound (lc) of the present invention by removing the protecting group represented by R 8 of the compound (16) in an inert solvent.
- This step can be performed in the same manner as in the ninth step.
- compound (6) is reacted with R 6a X (described above) in an inert solvent to produce compound (17).
- This step can be performed in the same manner as in the tenth step.
- This step is a step of producing compound (18) by removing the isopropylidene group of compound (17) using an acid in an inert solvent.
- This step can be performed in the same manner as in the sixth step.
- the compound (1 8) is reacted with Arukokishiami emissions R 8 0 NH z, it is a step for preparing Compound (1-9).
- This step can be performed in the same manner as in the eighth step.
- This step is a step of removing the protecting group represented by Ra of compound (19) in an inert solvent to produce the target compound (Id) of the present invention.
- This step can be performed in the same manner as in the ninth step.
- This step can be performed in the same manner as in the fourteenth step.
- compound (20) is produced by reacting compound (19) with R 9 X in an inert solvent.
- This step can be performed in the same manner as in the tenth step.
- compound (16a) is reacted with R 9 X in an inert solvent to produce compound (47).
- This step can be performed in the same manner as in the tenth step.
- this step in an inert solvent, to remove the protecting group represented by R e of the compound (20), it is a step for preparing the objective compound of the present invention (le).
- This step can be performed in the same manner as in the ninth step.
- this step in an inert solvent, to remove the protecting group represented by R 8 and R 7 of the compound (47), is a step for preparing the objective compound of the present invention (I f).
- This step can be performed in the same manner as in the ninth step.
- This step is a step of reacting compound (21) with compound (21a) using a base in an inert solvent to produce compound (22).
- ethers such as tetrahydrofuran and getyl ether are preferable, and as the base to be used, n-butyllithium is preferable.
- the reaction is usually performed at 178 ° C, and the reaction time is 10 minutes to 5 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration. Add water-immiscible organic solvent and wash with water
- the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be performed by a method commonly used for separating and purifying an organic compound, for example, the method described in the first step.
- This step is a step of reacting compound (22) with t-butyl bromoacetate in an inert solvent to produce compound (23).
- a combination of lithium diisopropylamide (LDA) and an ether such as tetrahydrofuran and getyl ether, or a mixture of dibutylboron triflate-triethylamine and methylene chloride, and methylform Combinations of such halogenated hydrocarbons are preferred.
- the reaction temperature, when using the LDA is usually one 7 8 gradually warmed to room temperature from a ⁇ 8 e C in the case of using dibutyl boron tri frame Bok.
- Anti The reaction time varies from 30 minutes to 1 day depending on the reagents and raw materials.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration. Add an organic solvent that is immiscible with clean water and wash with water etc.
- the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be performed by a method commonly used for separating and purifying an organic compound, for example, the method described in the first step.
- This step is a step of producing compound (2) by hydrolyzing compound (23) in an inert solvent using a base.
- a mixed solvent of tetrahydrofuran and water is preferable, and as a base to be used, an alkali metal hydroxide such as lithium hydroxide is preferable, and the reaction is carried out by adding hydrogen peroxide. Can be performed efficiently.
- the reaction temperature is usually from 0 to 5 CTC, and the reaction time is usually from 30 minutes to 5 hours, varying depending on a raw material and a reagent.
- the desired compound of this reaction according to a conventional method, collected from the reaction mixture, for example, the reaction mixture was appropriately neutralized, and, after removing by ⁇ if insoluble materials exist, acetic E 1 A water-immiscible organic solvent, such as toluene, is added, the organic layer containing the target compound is separated after washing with water or the like, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- acetic E 1 A water-immiscible organic solvent, such as toluene, is added, the organic layer containing the target compound is separated after washing with water or the like, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound may be subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separating and purifying an organic compound, for example, the method described in the first step described above. Can be.
- Step 28 Alkylation
- a known compound (24) is reacted with an arylhalide R′′X (X represents a halogen atom, preferably bromine or chlorine) using a base in an inert solvent to give a compound.
- R′′X represents a halogen atom, preferably bromine or chlorine
- ethers such as tetrahydrofuran and getyl ether are preferable.
- disilazides such as lithium hexamethyldisilazide and potassium hexamethyldisilazide, and lithium disoproviramide are preferable, and disilazides are more preferable.
- the reaction temperature is usually raised gradually from 18 C to room temperature.
- the reaction time varies depending on the reagents and raw materials, and is 1 to 20 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration.
- Such an organic solvent immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound may be subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separating and purifying an organic compound, for example, the method described in the first step described above. Can be.
- This step is a step of producing a compound (26) by reducing the double bond of the compound (25) in an inert solvent.
- the solvent to be used is not particularly limited as long as it does not participate in the reaction.
- the solvent include alcohols such as methanol, ethanol, and isopropanol; ethers such as dimethyl ether, tetrahydrofuran, and dioxane; Aromatic hydrocarbons such as toluene, benzene, xylene, aliphatic hydrocarbons such as hexane and cyclohexane, esters such as ethyl acetate and propyl acetate, formamide, dimethylformamide, Dimethylacetamide, N-methyl-2-viroli Amides such as methacrylic acid and hexane methyl phosphorotriamide, fatty acids such as formic acid and acetic acid, water, and a mixed solvent thereof are more preferable. Alcohols (particularly methanol) ), Esters (especially ethyl acetate).
- the catalyst to be used is not particularly limited as long as it is usually used in a catalytic reduction reaction, but is preferably palladium carbon, palladium black, Raney nickel, platinum oxide, platinum black, palladium aluminum monoxide Rhodium aluminum monoxide, triphenylphosphine-rhodium chloride and palladium barium monosulfate are used, preferably palladium carbon.
- the pressure is not particularly limited, but it is usually 1 to 10 atm.
- reaction temperature and reaction time vary depending on the type of the starting material, the solvent and the catalyst, but are usually 0 ° C to 10 CTC (preferably 20 to 50 ° C), 5 minutes to 48 hours. (Preferably 30 minutes to 10 hours).
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the solvent is distilled off if necessary, and the mixture is mixed with water such as ethyl acetate.
- An organic solvent containing no target compound is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound may be subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separating and purifying an organic compound, for example, the method described in the first step described above. Can be.
- This step is a step of producing a compound (27) by hydrolyzing the compound (26) using a base in an inert solvent.
- Alkali metal hydroxides such as potassium hydroxide and sodium hydroxide are suitable as the base used, and a mixed solvent of ethers and water such as dioxane and tetrahydrofuran is used as the solvent. It is.
- the reaction temperature is usually 60 to 100 ° C, and the reaction time varies depending on the raw material, base, etc. But usually 5 hours to 1 day.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method. Thereafter, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be performed by a method commonly used for separating and purifying an organic compound, for example, the method described in the first step.
- This step is a step of producing a compound (5) by simultaneously protecting the hydroxyl group and the carboxylic acid of the compound (27) by removing the generated water by azeotropic distillation in an inert solvent using an acid catalyst. It is.
- the solvent is not particularly limited as long as it does not inhibit the reaction, but preferably includes aromatic hydrocarbons such as benzene and toluene.
- the acid catalyst to be used is not particularly limited as long as it is usually used as an acid, but is preferably an organic acid such as p-toluenesulfonic acid, camphorsulfonic acid, or pyridium-P-toluenesulfonate. Or an inorganic acid such as hydrochloric acid.
- the reaction temperature varies depending on the acid catalyst used, the starting compound, etc., but is usually from 80 to 100, and the reaction time is mainly determined by the reaction temperature, the starting compound, and the type of solvent used. It usually varies from 30 minutes to 10 hours, depending on the situation.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insoluble substances are present, they are removed by filtration. It is obtained by adding an organic solvent immiscible with water, washing with water or the like, separating an organic layer containing the target compound, drying over anhydrous magnesium sulfate or the like, and distilling off the solvent.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method usually used for separating and purifying an organic compound, for example, the method described in the first step described above. be able to.
- ethers such as tetrahydrofuran and getyl ether are preferable.
- the reaction temperature is -78 to 0 C, and the reaction time varies depending on the raw materials, but is usually 10 minutes to 10 hours.
- the reaction can be carried out efficiently by using a copper salt such as copper iodide.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insoluble substances are present, they are removed by permeation. Add an organic solvent that is immiscible with water and wash with water, etc.
- the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- This step is a step of producing compound (34) by reacting compound (28) with methoxymethylamine in an inert solvent.
- This step is performed when R 17 is hydrogen, and is performed according to the active ester method and the condensation method described in the first step.
- the step is a step of reducing compound (28) in an inert solvent to produce compound (29).
- a mixed solvent of tetrahydrofuran and ethyl alcohol is preferable.
- the reducing agent to be used lithium borohydride or a combination of sodium borohydride and lithium chloride is suitable.
- the reaction temperature is usually 0 to 40 ° C, and the reaction time is usually 10 hours to 3 days.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method, for example, to reduce residual
- a water-immiscible organic solvent such as ethyl acetate, washing with water, etc., and containing the target compound
- the organic layer is separated, dried over anhydrous magnesium sulfate and the like, and then the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be performed by a method commonly used for separating and purifying an organic compound, for example, the method described in the first step.
- This step is a step of oxidizing compound (29) in an inert solvent to produce compound (30).
- This step can be performed by a method called Moffatt oxidation or Swern oxidation.
- the reaction temperature is usually 10 to 50 ° C, and the reaction time is usually 30 minutes to 5 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the remaining oxidizing agent is decomposed and neutralized as appropriate, and if insolubles are present, they are removed by filtration.
- an organic solvent immiscible with water such as ethyl acetate, is added, washed with water, etc., the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate, etc., and the solvent is distilled off. .
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be carried out by a method that has been used for separation and purification of organic compounds, for example, the method described in the first step.
- Step 36 Alkylation In this step, in an inert solvent, Compound (3 0) the alkylating agent R 4 M g X a are reacted in a step of producing the compound (3 1).
- This step can be performed in the same manner as in the 32nd step.
- This step is a step of producing a compound (32) by alkylating the compound (34) in an inert solvent.
- This step can be performed in the same manner as in the 32nd step.
- This step is a step of reacting compound (30) with a cyanating agent in an inert solvent to produce compound (35).
- a mixed solvent of a halogenated hydrocarbon such as methylene chloride and water is suitable.
- an alkali metal cyanide such as sodium cyanide or potassium cyanide and hydrochloric acid are used.
- the reaction temperature is usually from 0 to 40 ° C, and the reaction time is usually from 5 hours to 1 day, varying depending on a raw material, a reagent and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insoluble matter is present, it is removed by filtration.
- Such an organic solvent immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- Step 38 Hydrolysis This step is a step of hydrolyzing compound (35) under acidic conditions to produce compound (36).
- R 12 is a group that can be removed by an acid such as a tert-butoxycarbonyl group.
- Water is preferred as the solvent used.
- the acid to be used is not particularly limited as long as it is usually used, but hydrochloric acid is preferred.
- the reaction temperature is usually from 60 to 100 ° C, and the reaction time is usually from 5 to 24 hours, depending on the starting materials, reagents and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method, and can be obtained, for example, by filtering off the crystals generated by concentrating the reaction mixture.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- This step is a step of hydrolyzing compound (36) using a base in an inert solvent to produce compound (37).
- R ′ 2 is an acid-stable group such as a benzyloxycarbonyl group.
- This step can be performed in the same manner as in the 26th step.
- This step is a step of producing a compound (40) by hydrolyzing the compound (39) using a base in an inert solvent.
- This step can be performed in the same manner as in the thirtieth step.
- This step is a step of producing compound (41) by condensing compound (40) and a desired amine in an inert solvent.
- This step can be performed in the same manner as in the first step.
- a mixed acid anhydride is synthesized from compound (42) in an inert solvent and then reacted with diazomethane to produce compound (43).
- the reaction for producing the mixed acid anhydride is carried out in an inert solvent (for example, the above-mentioned halogenated hydrocarbons, amides, and ethers (preferably, ethyl ether)) in a mixed acid anhydride agent such as chloro.
- Ethyl carbonate, lower (C,-) alkyl halides such as isobutyl chlorocarbonate, lower alkanol halides such as vivacyl chloride, or lower alkyls or phenyls such as getylcyanophosphate, diphenylcyanophosphate. This is achieved by reacting compound (42) with lucyanophosphoric acid or the like.
- the reaction is preferably performed in the presence of an organic amine such as triethylamine, N-methylmorpholine, dimethylaminoviridine, pyridine, and the reaction temperature is 120 ° C to 0 ° C, and the time required for the reaction is Is from 30 minutes to 1 hour.
- the reaction between the mixed acid anhydride and diazomethane is preferably performed in an inert solvent (for example, the above-mentioned ethers) at a reaction temperature of 0 ° C. to 50 ° C., and the time required for the reaction is 1 to 10 hours. It is.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method. For example, when insolubles are present, they are removed by filtration and then the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be performed by a method commonly used for separating and purifying an organic compound, for example, the method described in the first step.
- a solvent using a desired alcohol or acid, or an ether such as dioxane or tetrahydrofuran is preferable.
- Suitable catalysts are copper salts such as cupric acetate, cupric chloride and copper oxide.
- the reaction temperature is usually from 20 to 100 ° C., and the reaction time is usually from 10 minutes to 3 hours, depending on raw materials and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration.
- Such an organic solvent immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- Step 46 Reduction In this step, compound (44) is reduced in an inert solvent to produce compound (45).
- This step is performed when R 18 is an acyl group.
- This step can be performed in the same manner as in the thirty-fourth step.
- R 18 is an alkyl group
- R 18 is not removed, and a compound corresponding to compound (53) can be obtained.
- compound (39) is reduced in an inert solvent to produce compound (46).
- This step can be performed in the same manner as in the thirty-fourth step.
- This step is a step of producing compound (33) by reacting compound (32) with alkylating agent R 4 MgX 8 in an inert solvent.
- This step can be performed in the same manner as in the thirty-second step.
- This step is a step of producing a compound (48) by reacting the compound (34) with an aryl Grignard reagent in an inert solvent.
- This step can be performed in the same manner as in the thirty-seventh step.
- This step is a step of producing compound (49) from compound (48) in an inert solvent.
- This step can be carried out by a method called hydroboration-hydrogen peroxide oxidation method.
- ethers such as getyl ether and tetrahydrofuran, and aromatic hydrocarbons such as benzene and toluene are preferable.
- borating reagent to be used 9-borabicyclo [3,3,1] nonane, borane-dimethylthioether complex and the like are suitable.
- the reaction temperature for volatilization is usually 10 to 50 ° C, and the reaction time is usually 1 to 10 hours.
- Subsequent oxidation is performed by using hydrogen peroxide in water in the presence of sodium hydroxide.
- the reaction temperature is usually 0 to 40 ° C, and the reaction time is usually 10 minutes to 5 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the remaining oxidizing agent is decomposed, the reaction mixture is appropriately neutralized, and if there is an insoluble substance, the compound is renatured.
- an organic solvent that is immiscible with water such as ethyl acetate, wash with water, etc., separate the organic layer containing the target compound, dry with anhydrous magnesium sulfate, etc., and evaporate the solvent Obtained by:
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- This step is a step of reacting compound (49) with a reducing agent in an inert solvent to produce compound (50).
- alcohols such as methanol and ethanol are suitable.
- sodium borohydride is preferable.
- the reaction temperature is usually 0 ° C to 40 ° C, and the reaction time varies depending on the raw material and the reducing agent, but is usually 1 hour to 1 hour.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the remaining reducing agent is decomposed, the reaction mixture is appropriately neutralized, and if an insoluble substance is present, the reaction is performed.
- an organic solvent that is immiscible with water such as ethyl acetate, wash with water, etc., separate the organic layer containing the target compound, dry with anhydrous magnesium sulfate, etc., and evaporate the solvent Obtained by:
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- the method can be performed by a method commonly used for separating and purifying an organic compound, for example, the method described in the first step.
- compound (51) is reacted with t-butyldimethylsilyl halide in an inert solvent using a base to produce compound (52).
- halogenated hydrocarbons such as methylene chloride and black form
- ethers such as getyl ether and tetrahydrofuran
- amides such as dimethylformamide are preferable.
- Suitable bases used are organic amines such as triethylamine, 4,4-dimethylaminopyridine and imidazole.
- the reaction temperature is usually 0 to 40 ° C, and the reaction time is 30 minutes to 5 hours, depending on the raw materials and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method, ⁇
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration.
- a water-immiscible organic solvent such as ethyl acetate is added, and the target compound is washed with water or the like. It is obtained by separating the organic layer containing, drying over anhydrous magnesium sulfate or the like, and distilling off the solvent.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- Compound (5 1) by reacting Ashiruharai de R 1 6 X or R 1 6 OR 1 6, is a step for preparing a compound (5 3).
- This step can be performed in the same manner as in the tenth step.
- This step is a step of reacting compound (51) with p-toluenesulfonyl halide (or anhydride) in an inert solvent to produce compound (54).
- halogenated hydrocarbons such as methylene chloride and black form
- ethers such as getyl ether and tetrahydrofuran
- amides such as dimethylformamide are preferable. is there.
- organic amines such as triethylamine, 4,4-dimethylaminopyridin and imidazole are preferable.
- the reaction temperature is usually 0 to 40 ° C, and the reaction time is 30 minutes to 24 hours, depending on the raw materials and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration.
- Such an organic solvent immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- halogenated hydrocarbons such as methylene chloride and black form
- ethers such as getyl ether and tetrahydrofuran
- amides such as dimethylformamide are preferable. .
- Suitable bases to be used are organic amines such as triethylamine and 4,4-dimethylaminopyridin.
- the reaction temperature is usually from 20 to 100, and the reaction time is from 30 minutes to 24 hours, depending on raw materials and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration.
- Such an organic solvent immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- ethers such as getyl ether and tetrahydrofuran are preferable.
- Suitable bases used are alkali metal hydrides such as sodium hydride and potassium hydride, and alkyllithiums such as n-butyllithium.
- the reaction temperature is usually 20 to 60 ° C, and the reaction time is 30 minutes to 24 hours, depending on the raw materials and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insoluble substances are present, they are removed by filtration. It is obtained by adding an organic solvent immiscible with water, washing with water or the like, separating an organic layer containing the target compound, drying over anhydrous magnesium sulfate or the like, and distilling off the solvent.
- the obtained target compound may be subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separating and purifying an organic compound, for example, the method described in the first step described above.
- a conventional method for example, recrystallization, reprecipitation, or a method generally used for separating and purifying an organic compound, for example, the method described in the first step described above.
- the hydroxyl group of compound (54) is protected immediately before Steps 55 and 56, and the hydroxyl group is deprotected immediately after Steps 55 and 56.
- the desired compounds (55) and (56) As the protecting group for the hydroxyl group, a tetrahydrobiranyl group and a methoxymethyl group are suitable, and protection and deprotection are performed by a conventional method.
- This step is a step of reacting compound (51) with an oxidizing agent in an inert solvent to produce compound (57).
- Amides such as dimethylformamide are suitable as the solvent to be used, and pyridinum chromatochromate and pyridinium dichromate are suitable as the oxidizing agent to be used.
- the reaction can be performed efficiently by using molecular sieve 4A.
- the reaction temperature is usually 10 to 40 ° C, and the reaction time varies depending on the raw materials and the like. o minutes to 5 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the remaining oxidizing agent is decomposed, the reaction mixture is appropriately neutralized, and, if insoluble matters are present, filtration is performed.
- an organic solvent that is immiscible with water such as ethyl acetate, wash with water, etc., separate the organic layer containing the target compound, dry with anhydrous magnesium sulfate, and distill off the solvent.
- the obtained target compound may be used in a conventional manner, for example, recrystallization, reprecipitation, or
- This step is a step of producing a compound (58) by reacting the compound (57) with an alcohol in an inert solvent.
- This step is performed according to the active ester method or the condensation method of the first step. (Step 59) Reduction
- This step is a step of producing a compound (59) by reacting the compound (58) with a reducing agent in an inert solvent.
- This step can be performed in the same manner as in the 51st step.
- halogenated hydrocarbons such as methylene chloride and chloroform are preferred; ethers such as dimethyl ether and tetrahydrofuran; and amides such as dimethylformamide are suitable.
- the reaction temperature is usually 20 to 100 ° C, and the time varies depending on the raw materials and the like, but is usually 1 hour to 3 days.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration.
- An organic solvent that is immiscible with water is added, washed with water or the like, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- the compound (60) is produced by reducing the ketone of the compound (57) according to the 59th step, and then condensing it with an amine according to the active ester method or the condensation method of the 1st step. You can also.
- compound (30) is reacted with arylmagnesium halide (preferably, promide or chloride) using a base in an inert solvent to produce compound (61). is there.
- arylmagnesium halide preferably, promide or chloride
- This step can be performed according to step 36.
- compound (61) is reacted with t-butyldimethylsilyl halide in an inert solvent to produce compound (62).
- This step can be performed in the same manner as in the 52nd step.
- This step is a step of producing a compound (63) by reacting the compound (62) with an oxidizing agent in an inert solvent.
- This step is performed by oxidizing with sodium periodate after the dihydroxylation reaction.
- the dihydroxylation reaction and sodium periodate oxidation can be performed simultaneously.
- ethers such as ethyl ether and tetrahydrofuran, and aromatic hydrocarbons such as benzene and toluene are preferable.
- the dihydroxylating reagent to be used a combination of osmium tetroxide or smear oxide and a co-oxidant such as N-methylmorpholine N-oxide is preferable.
- the reaction temperature for boration is usually 0 to 5 crc, and the reaction time is usually 1 to 10 hours.
- the subsequent oxidation takes place in a mixed solvent of water and alcohols such as methanol.
- the reaction is carried out by using sodium periodate.
- the reaction temperature is usually 0 to 40 ° C, and the reaction time is usually 10 minutes to 3 hours.
- the remaining oxidizing agent is decomposed, the reaction mixture is appropriately neutralized, and if insolubles are present, they are removed by filtration, and then an organic solvent immiscible with water, such as ethyl acetate, is added.
- the organic layer containing the target compound is separated after washing with, for example, and dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- This step is a step of producing a compound (64) by reacting the compound (63) with ethyl ethylphosphonoacetate in an inert solvent in the presence of a base.
- the solvent used in the Wittig reaction is not particularly limited as long as it does not hinder the reaction and dissolves the starting material to some extent.
- it is dimethyl ether, disopropyl ether, or tetraethyl ether. These are ethers such as lahydrofuran.
- the reaction temperature is usually 0 to 4 (TC), and the reaction time is usually 30 minutes to 20 hours, depending on the raw materials and the like.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is appropriately neutralized, and if insoluble substances are present, they are removed by filtration. It is obtained by adding an organic solvent immiscible with water, washing with water or the like, separating an organic layer containing the target compound, drying over anhydrous magnesium sulfate or the like, and distilling off the solvent.
- the obtained target compound is subjected to a conventional method, for example, recrystallization, reprecipitation, or a method generally used for separation and purification of organic compounds, for example, the method described in the first step described above. Can be.
- This step is a step of producing a compound (65) by reacting the compound (64) with a reducing agent in an inert solvent. This step can be performed in the same manner as in the 29th step.
- compound (65) is reacted with compound (65) in an inert solvent to produce compound (66).
- This step can be performed in the same manner as in the forty-seventh step.
- This step is a step of reacting compound (66) with a deprotecting agent in an inert solvent to produce compound (67).
- Compound (3) and compound (7) are compound (33), compound (31), compound (32a), compound (38), compound (39), compound (41), compound (45), compound (46), compound (50), compound (51), compound (52), compound (53), compound (55), compound (56), compound (59), compound (60), and compound (67) the protective group represented by the R 12, by conventional method carried out, obtained by divided.
- the present invention relates to a novel hydroxamic acid derivative having an excellent matrix metalloproteinase inhibitory activity, and an agent for suppressing metastasis, invasion and growth of various cancer cells, and an osteoarthritis and rheumatism containing the derivative as an active ingredient.
- a therapeutic agent and a preventive agent for rheumatoid arthritis are provided.
- the dosage form of the compound (1) of the present invention include oral administration such as tablets, capsules, granules, powders or syrups, and parenteral administration such as injections or suppositories.
- preparations may contain excipients (eg, lactose, sucrose, dextrose, saccharides such as mannitol, sorbitol; corn starch, potato starch, ⁇ -starch, dextrin, starch such as carboxymethyl starch).
- excipients eg, lactose, sucrose, dextrose, saccharides such as mannitol, sorbitol; corn starch, potato starch, ⁇ -starch, dextrin, starch such as carboxymethyl starch.
- Cellulose derivatives such as crystalline cellulose, low-substituted hydroxypropyl cellulose, hydroxypropyl methylcellulose, carboxymethylcellulose, carboxymethylcellulose calcium, and internally crosslinked carboxymethylcellulose sodium; arabia gum; dextran Organic excipients such as pullulan: and silicate derivatives such as light silicic anhydride, synthetic aluminum silicate, magnesium metasilicate aluminate; phosphates such as calcium phosphate; carbonates such as calcium carbonate; Sulfuric acid Inorganic excipients such as sulfates such as sodium chloride, etc.), lubricants (for example, metal stearates such as stearic acid, calcium stearate, magnesium stearate; talc; colloidal silica) Waxes such as veegum and gay; boric acid; adipic acid; sulfates such as sodium sulfate; glycol; fumaric acid; sodium benzoate; DL le
- Stabilizers paraoxybenzoic acid esters such as methylparaben and propylparaben; alcohols such as chlorobutanol, benzyl alcohol and phenylethyl alcohol; benzalkonium chloride; phenols such as phenol and cresol; thimerosal Dehydroacetic acid; and sorbic acid
- flavoring agents for example, commonly used sweeteners, sour agents, flavors, etc.
- the dosage varies depending on the symptoms, age, administration method, etc.
- the lower limit is 1 mg (preferably 10 mg) and the upper limit is 10 OO mg
- the lower limit is preferably 0.5 mg (preferably 5 mg) and the upper limit is 500 mg (preferably 25 mg).
- Omg is preferably administered once or several times daily depending on the symptoms.
- N 1 one Benjiruokishi N 4 - [1 - (S ) one t one-butyl - 2- (R) - arsenide Dorokishi 3- (N- methylcarbamoyl) propyl] one 2-(S) over human Dorokishi one 3— (R) -nonylsuccinamide
- N 1 one Benjiruokishi N 4 one [1 one (S) - t-butyl-2- (R), 4- dihydric Dorokishibuchiru] one 2 - (S) over human Dorokishi one 3 - (R) - Noel Sukushinami de
- the target compound (340 mg, 74.0%) was obtained as a white compound from (R) -nonylsuccinamide (550 mg) in the same manner as in Example 2-c).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cette invention concerne des composés correspondant à la formule générale (1) où R1 représente alkyle C¿1-15? éventuellement substitué; R2 représente H, hydroxy ou acyloxy C1-4; R?3¿ représente alkyle C¿1-6? éventuellement substitué; R?4¿ représente H, alcoxycarbonyle C¿2-5? ou alkyle C1-4 éventuellement substitué; R?5¿ représente H ou alkyle C¿1-4?; et R?6¿ représente H, acyle C¿2-5? éventuellement substitué ou carbamoyle éventuellement substitué. Ces composés possède une excellente activité inhibitrice de métaprotéinases matricielles, et peuvent être utilisés en qualité d'inhibiteurs de métastase cancéreuse, entre autres.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU18121/97A AU1812197A (en) | 1996-03-01 | 1997-02-27 | Hydroxamic acid derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8/44830 | 1996-03-01 | ||
JP4483096 | 1996-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997031892A1 true WO1997031892A1 (fr) | 1997-09-04 |
Family
ID=12702388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/000582 WO1997031892A1 (fr) | 1996-03-01 | 1997-02-27 | Derives d'acide hydroxamique |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1812197A (fr) |
WO (1) | WO1997031892A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055449A1 (fr) * | 1997-06-06 | 1998-12-10 | The University Of Queensland | Composes d'acide hydroxamique ayant des proprietes anticancereuses et antiparasitaires |
WO2001047901A1 (fr) * | 1999-12-23 | 2001-07-05 | Pfizer Limited | Acides ox(adi)azolyl-hydroxamiques utilises comme inhibiteurs de la procollagene c-proteinase |
US6448278B2 (en) | 1999-12-23 | 2002-09-10 | Pfizer Inc. | Procollagen C-proteinase inhibitors |
WO2014067861A1 (fr) * | 2012-10-29 | 2014-05-08 | F. Hoffmann-La Roche Ag | Dérivés d'oxazolidinone 3,4-disubstituée et leur utilisation comme inhibiteurs des canaux potassiques activés par le calcium |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991008222A1 (fr) * | 1989-11-24 | 1991-06-13 | Banyu Pharmaceutical Co., Ltd. | Substance physiologiquement active be-16627 |
WO1994025434A1 (fr) * | 1993-04-27 | 1994-11-10 | Celltech Limited | Derives peptidiques inhibiteurs de metalloproteinases |
WO1995019961A1 (fr) * | 1994-01-22 | 1995-07-27 | British Biotech Pharmaceuticals Limited | Inhibiteurs de metalloproteinase |
WO1996033166A1 (fr) * | 1995-04-18 | 1996-10-24 | The Du Pont Merck Pharmaceutical Company | Acides hydrodynamiques et carboxyliques inhibiteurs des metalloproteases |
WO1996033165A1 (fr) * | 1995-04-18 | 1996-10-24 | British Biotech Pharmaceuticals Limited | Derives de succinamide et leur utilisation en tant qu'inhibiteurs de la metalloproteinase |
-
1997
- 1997-02-27 AU AU18121/97A patent/AU1812197A/en not_active Abandoned
- 1997-02-27 WO PCT/JP1997/000582 patent/WO1997031892A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991008222A1 (fr) * | 1989-11-24 | 1991-06-13 | Banyu Pharmaceutical Co., Ltd. | Substance physiologiquement active be-16627 |
WO1994025434A1 (fr) * | 1993-04-27 | 1994-11-10 | Celltech Limited | Derives peptidiques inhibiteurs de metalloproteinases |
WO1995019961A1 (fr) * | 1994-01-22 | 1995-07-27 | British Biotech Pharmaceuticals Limited | Inhibiteurs de metalloproteinase |
WO1996033166A1 (fr) * | 1995-04-18 | 1996-10-24 | The Du Pont Merck Pharmaceutical Company | Acides hydrodynamiques et carboxyliques inhibiteurs des metalloproteases |
WO1996033165A1 (fr) * | 1995-04-18 | 1996-10-24 | British Biotech Pharmaceuticals Limited | Derives de succinamide et leur utilisation en tant qu'inhibiteurs de la metalloproteinase |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055449A1 (fr) * | 1997-06-06 | 1998-12-10 | The University Of Queensland | Composes d'acide hydroxamique ayant des proprietes anticancereuses et antiparasitaires |
WO2001047901A1 (fr) * | 1999-12-23 | 2001-07-05 | Pfizer Limited | Acides ox(adi)azolyl-hydroxamiques utilises comme inhibiteurs de la procollagene c-proteinase |
US6448278B2 (en) | 1999-12-23 | 2002-09-10 | Pfizer Inc. | Procollagen C-proteinase inhibitors |
US6897306B2 (en) | 1999-12-23 | 2005-05-24 | Pfizer Products, Inc. | 3-heterocyclylpropanohydroxamic acids |
WO2014067861A1 (fr) * | 2012-10-29 | 2014-05-08 | F. Hoffmann-La Roche Ag | Dérivés d'oxazolidinone 3,4-disubstituée et leur utilisation comme inhibiteurs des canaux potassiques activés par le calcium |
US9611232B2 (en) | 2012-10-29 | 2017-04-04 | Hoffmann-La Roche Inc. | Oxazolidinone and imidazolidinone compounds |
Also Published As
Publication number | Publication date |
---|---|
AU1812197A (en) | 1997-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240174710A1 (en) | Compounds, compositions and methods for synthesis | |
CN111574577B (zh) | 鹅去氧胆酸衍生物 | |
KR0177838B1 (ko) | 인체 면역 결핍 비루스(hiv) 프로테아제의 활성을 억제할 수 있는 펩티드, 그의 제조 방법, 및 그의 치료적 용도 | |
ES2394480T3 (es) | Derivado de isoxazolina y nuevo procedimiento para su preparación | |
EP3686196B1 (fr) | Composé polycyclique agissant en tant qu'inhibiteur de l'ido et/ou en tant qu'inhibiteur double de l'ido-hdac | |
CA3020585A1 (fr) | Compositions de conjugues d'acides nucleiques cibles | |
KR0138498B1 (ko) | 신규 이속사졸 유도체 및 그의 염 | |
EP0309766A2 (fr) | Dérivés N-acylés d'aminoacides et leur utilisation | |
BR112013026466A2 (pt) | derivados de ácido 3-fenilpropiônico ramificados e o seu uso | |
WO1993009090A1 (fr) | Derive d'acide hydroxamique | |
CZ200425A3 (cs) | Deriváty aromatických dikarboxylových kyselin | |
EP4132650B1 (fr) | Dérivés de difluorocyclohexyle utilisés en tant que modulateurs d'il -17 | |
WO2008038768A1 (fr) | Composé ayant une structure de pyrimidine bicyclique et composition pharmaceutique comprenant le composé | |
CZ103594A3 (en) | Peptide analogs as irreversible inhibitors of interleukin-1beta-protease | |
JP2020510063A (ja) | Mk2阻害剤、その合成、およびそれに至るまでの中間体 | |
US5478856A (en) | Styrene derivatives and salts thereof | |
WO2003059866A1 (fr) | Composes de geranyle | |
CN114591201B (zh) | 具有HDACi药效团的β-榄香烯衍生物及其制备方法和应用 | |
CN110117293B (zh) | 多氟取代的Largazole类似物、其制备方法和用途 | |
CA2329660A1 (fr) | Inhibiteurs de neuraminidases | |
CN103626825A (zh) | 靶向肝脏的糖原磷酸化酶抑制剂胆酸类衍生物、其制备方法及医药用途 | |
EP1661882A1 (fr) | Compose presentant une activite anti-vhc et procede de production de ce dernier | |
EP2233467B1 (fr) | Amides n-substitués par alpha-amino, composition pharmaceutique les contenant et leurs utilisations | |
WO1997031892A1 (fr) | Derives d'acide hydroxamique | |
EP0320988A2 (fr) | Dérivé 4-acyl de l'epipodophyllotoxineglucoside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN CZ HU KR MX NO NZ RU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: CA Ref document number: 2247451 Kind code of ref document: A Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase |